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ABSTRACT 
 
 
Holloway, Laurin Nicole. M.S., Department of Biological Sciences, Microbiology and 
Immunology Program, Wright State University, 2009.  Host Defense Mechanisms 
Against Mycobacterium tuberculosis.     
 
 
Mycobacterium tuberculosis is one of the world’s most infectious diseases.  
Approximately 2 million people die each year from Mycobacterium tuberculosis 
infection and one-third of the world’s population remains infected.  For decades research 
has focused on uncovering the tactics used by Mycobacterium tuberculosis to evade host 
immune responses and defense mechanisms used to fight tuberculosis infection.  The 
following review focuses on the host defense mechanisms used to combat 
Mycobacterium tuberculosis with an emphasis placed on the roles that Toll-like receptors 
(TLRs), T cells (γδ, CD4+, CD8+
 
), and macrophages play in mounting the innate and 
adaptive immune responses necessary to eradicate this disease.  The challenges of 
designing an effective vaccine to fight Mycobacterium tuberculosis infection and the two 
first-line anti-tuberculosis inhalant drugs, Isoniazid (H) and Rifampicin (R) are also 
discussed.   
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SIGNIFICANCE  
 Mycobacterium tuberculosis is a devastating disease that affects a large portion of 
the world’s population.  The fight against Mycobacterium tuberculosis infection is 
currently a battle that is lifelong given that at the moment there is no vaccine that is 100% 
effective or a cure.  The fact that latent Mycobacterium tuberculosis infection continues 
to pose the threat of reactivation at any moment puts more individuals at risk of 
contracting Mycobacterium tuberculosis infection.  With the increasing number of 
immigrants entering into the United States from countries where adequate healthcare is 
minimal to nonexistent, it is vital that all of the necessary precautions are taken to prevent 
the incidence of Mycobacterium tuberculosis infection.  
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INTRODUCTION 
 The likelihood of becoming infected with Mycobacterium tuberculosis is 
multifactoral (Raja, 2004).  Mycobacterium tuberculosis is the second leading cause of 
death among all infectious diseases worldwide.  Approximately 2 million people die each 
year from Mycobacterium tuberculosis (Davis et al., 2007) and one-third of the world’s 
population remains infected with latent disease (van Crevel et al., 2002).   
Naturally there are individuals who are more susceptible to mycobacterial 
infections than others.  Individuals reported as having an increased risk of contracting 
mycobacterial infections include individuals that have suffered chronic renal failure, 
individuals with insulin-dependent diabetes, individuals undergoing immunosuppressive 
therapy, residents of prisons and homeless shelters, intravenous-drug users, and 
individuals infected with HIV (Horsburgh, 2004).  These specific individuals’ increased 
susceptibility to Mycobacterium tuberculosis may stem from a decrease in their immune 
system’s ability to prevent infection, progression to primary infection, and infection 
reactivation (Horsburgh, 2004).   
The objective of the following review is to examine the host defense mechanisms 
used to combat Mycobacterium tuberculosis with an emphasis placed on the roles that 
Toll-like receptors (TLRs), T cells (γδ, CD4+, CD8+), and macrophages play in mounting 
the innate and adaptive immune responses necessary to eradicate this disease. 
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INITIAL MYCOBACTERIUM TUBERCULOSIS INFECTION 
 Mycobacterium tuberculosis can cause infection anywhere within the body, 
although it mainly takes hold and resides within the lungs of infected individuals (van 
Crevel et al., 2002).  Consequently, the route of infection plays an important role in 
determining how signal transduction, immune activation, and the  intracellular survival of 
Mycobacterium tuberculosis occur (van Crevel et al., 2002). Mycobacterium tuberculosis 
is the most virulent of mycobacteria (Pieters et al., 2002).  Mycobacteria are slow 
growing organisms that limit themselves to mainly infecting macrophages of the host 
(Pieters et al., 2002), specifically macrophages of the lung (alveolar macrophages) (van 
Crevel et al., 2002). Mycobacteria reside in structures known as phagosomes.  Normally 
bacteria ingested by alveolar macrophages are destroyed within lysosomes that fuse with 
phagosomes.  In contrast, Mycobacterium tuberculosis prevents lysosomal fusion with 
phagosomes.  The failed fusion of these two structures prevents the formation of a third 
structure known as the phagolysosome, consequently leading to the mycobacteria’s 
avoidance of degradation and destruction within the macrophage, contributing to the 
survival of Mycobacterium tuberculosis infection (Pieters et al., 2002).  This ability to 
evade destruction by the alveolar macrophage limits the immune response of the host to 
containing the infection, not eliminating it (Flynn et al., 2001).   
Initiation of Mycobacterium tuberculosis infection begins with the inhalation of 
tubercle bacilli.  Following inhalation, the tubercle bacilli are ingested by alveolar 
macrophages, resulting in either their destruction or persistence.  The tubercle bacilli that 
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are capable of escaping destruction then multiply and disrupt the function of the alveolar 
macrophage.  When the actions of the alveolar macrophage become disrupted, other 
inflammatory cells programmed to prevent the spread of infection are then recruited to 
the site of infection within the lungs.  Following inhalation of the tubercle bacilli, the 
mycobacteria are either destroyed, in which case no infection occurs, or the mycobacteria 
remain viable.  In the event that the mycobacteria are not destroyed, a primary complex 
forms.  The primary complex consists of Mycobacterium tuberculosis infiltrate and a 
draining lymph node.  The primary complex gives rise to the positive skin test that marks 
the Mycobacterium tuberculosis-specific T cell response, uncovering the existence of 
infection.  Once Mycobacterium tuberculosis infection has been established, the infection 
is usually stabilized and goes into latency.  In some cases however, the infection is not 
stabilized and active disease develops (primary tuberculosis infection).  Active 
tuberculosis infection in turn uses one of two methods to remain active within the host.  
Active tuberculosis disease either remains localized, keeping infection limited to the 
lungs, or it disseminates and travels to other areas of the body.  In the event of 
Mycobacterium tuberculosis dissemination, infection stabilization and latency are still 
possible however, large amounts of mycobacteria traveling throughout the body (miliary 
tuberculosis) and meningitis remain risks.  Although establishing a state of latency in a 
Mycobacterium tuberculosis-infected individual is one means of controlling tuberculosis 
infection, there always remains the risk of latent infection becoming reactivated in the 
event of immune surveillance failure, thereby establishing post-primary Mycobacterium 
tuberculosis infection (Fig. 1) (van Crevel et al., 2002). 
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FIG. 1 Chronological events after inhalation of Mycobacterium tuberculosis.   Adapted from van Crevel 
et al., 2002 
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CONTROLLING DISSEMINATION WITHIN THE INFECTED HOST 
 
Granuloma Formation 
 Within 2 to 6 weeks following Mycobacterium tuberculosis infection, cell-
mediated immunity leads to granuloma formation (Raja, 2004; van Crevel et al., 2002).  
Granulomas consist of lymphocytes and macrophages and are protective structures that 
prevent the spread of infection to other parts of the body by localizing the inflammation 
and damage.  Granulomas surround the bacteria-infected cells and starve them from 
nutrients that are essential for their survival.  In the case of Mycobacterium tuberculosis 
infection, granulomas function to keep the infection localized within the lungs (Salgame, 
2005).  Tuberculous granulomas consist of epitheliod macrophages, T cells (CD4+ and 
CD8+
Formation of Three Granuloma Types 
), B cells, and fibroblasts (Fig. 2) (Co et al., 2004 as reviewed by Salgame, 2005).  
Lymphocytes and multinucleated Langerhans giant cells may also be found in a central 
location, surrounded by macrophages within the granuloma (Peters et al., 2003).   
Three types of granulomas are capable of forming during a granulomatous 
response to Mycobacterium tuberculosis: the noncaseating granuloma, the caseating 
granuloma, and the reactivating granuloma (as reviewed by Salgame, 2005).  Although 
there is no direct evidence, the caseating and reactivating granulomas may arise from 
noncaseating granulomas (Salgame, 2005).  The noncaseating granuloma consists of 
CD4+ and CD8+ T cells, B cells, and macrophages harboring few tubercle bacilli.  This 
specific granuloma is also surrounded by a layer of fibroblasts.  Phagocytes carrying 
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tubercle bacilli from secondary infection sites migrate to these types of granulomas.  
Caseating granulomas are the classic type of granulomas found within tuberculosis 
patients.  Caseating granulomas contain a central necrotic area that contains extracellular 
bacteria surrounded by macrophages and phagocytes.  This specific granuloma also 
contains lymphoid follicle-like structures that are rich in T and B cells, and macrophages 
that contain tubercle bacilli.  A reactivating granuloma is a very disorganized granuloma 
type that exhibits enhanced Mycobacterium tuberculosis replication.  The reactivating 
granuloma is the least effective in fighting against Mycobacterium tuberculosis infection 
(Fig. 2) (Salgame, 2005). 
 
FIG. 2 The three types of granulomas capable of forming during the granulomatous response to 
Mycobacterium tuberculosis.  Adapted from Salgame, 2005 
 
Cytokines Involved in the Host Defense Response Against Mycobacterium tuberculosis 
Interleukin 1 Beta (IL-1β) 
 IL-1β is a proinflammatory cytokine produced mainly by monocytes, 
macrophages, and dendritic cells during an immune response to Mycobacterium 
8 
 
tuberculosis (as reviewed by van Crevel et al., 2002).  IL-1β is a key cytokine that plays 
an important role in the acute phase response to mycobacterial infection by inducing 
fever and cachexia (Raja, 2004).  IL-1β is found in excess in tuberculosis patients (Schauf 
et al., 1993 as reviewed by van Crevel et al., 2002).   IL-1R type-1-deficient mice 
displayed an increased susceptibility to mycobacterial outgrowth as well as defective 
granuloma formation following infection with Mycobacterium tuberculosis (Juffermans 
et al., 2000).  This finding supports the importance of IL-1β in battling Mycobacterium 
tuberculosis infection. 
Interleukin 6 (IL-6) 
IL-6 is a cytokine that possesses both pro- and anti-inflammatory properties 
(VanHeyningen et al., 1997 as reviewed by van Crevel et al., 2002).  IL-6 plays multiple 
roles during an immune response, including inflammation, hematopoiesis, and 
differentiation of T cells (Flynn et al., 2001).  IL-6 is produced early in mycobacterial 
infections but also has the potential to be harmful in these infections by inhibiting the 
production of both TNF-α and IL-1β (Sallusto et al., 2000 as reviewed by van Crevel et 
al., 2002).   IL-6 knockout mice administered a low dose of aerosolized tubercle bacilli 
maintained a higher bacterial load in the lungs and had decreased IFN-γ production 
(Saunders et al., 2000).  This decrease in IFN-γ production may contribute to the 
increased susceptibility of IL-6-deficient mice to Mycobacterium tuberculosis infection. 
Interleukin 12 (IL-12) 
 IL-12 is a very important cytokine with a key role in host defenses against 
Mycobacterium tuberculosis.  IL-12 is produced by activated macrophages following 
phagocytosis of tubercle bacilli, triggering a TH1 response and IFN-γ production.  Mice 
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deficient in the IL-12p40 gene were highly susceptible to intravenous infection with 
Mycobacterium tuberculosis and were unable to control bacterial growth in the lung.  The 
mice also had a decreased survival time, reflecting the decrease in IFN-γ production 
(Cooper et al., 1997).  Humans with mutations in either the IL-12p40 gene or IL-12R 
gene also showed a reduction in IFN-γ production, however, they were susceptible to 
disseminated Bacillus Calmette-Guerin (BCG) and Mycobacterium avium infections, not 
Mycobacterium tuberculosis (Ottenhoff et al., 1998).  In a study with BABL/c mice, a 
mouse strain highly susceptible to Mycobacterium tuberculosis infection, administration 
of IL-12 early during infection significantly decreased the bacterial burden within their 
lungs; however, the mice eventually succumbed to infection and died (Flynn et al., 1995).  
In contrast, IL-12 had only marginal effects on the bacterial numbers in the lungs of 
C57BL/6 mice (Cooper et al., 1995).  The difference in the results presented by these two 
sets of mice possibly result from the naturally resistant phenotype of the C57BL/6 mouse 
to tubercle bacilli. 
Interleukin 10 (IL-10) 
 IL-10 is an anti-inflammatory cytokine produced by macrophages and T cells 
during Mycobacterium tuberculosis infection and antagonizes proinflammatory responses 
by downregulating IFN-γ, TNF-α, and IL-12 production (Flynn et al., 2001).  
Downregulation of proinflammatory cytokines by IL-10 inhibits CD4+ T cell responses 
and the function of mycobacteria-infected antigen presenting cells (APCs) (Rojas et al., 
1999 as reviewed by Flynn et al., 2001).  Intravenously BCG-infected IL-10 transgenic 
mice developed a large bacterial burden in the spleen and liver (Murray et al., 1997), 
contrasting from intravenously BCG-infected IL-10-deficient mice that displayed a 
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bacterial burden comparable to the control (Murray et al., 1999).  In human tuberculosis, 
IL-10 production was shown to be higher in peripheral blood monocytes (PBMCs) of 
anergic tuberculosis patients both before and following stimulation with purified protein 
derivative (PPD).  This finding suggests that Mycobacterium tuberculosis-induced IL-10 
production is responsible for suppressing an effective immune response (Boussiotis et al., 
2000). 
Transforming Growth Factor Beta (TGF-β) 
  TGF-β is an anti-inflammatory cytokine produced by monocytes following the 
detection of mycobacterial products (Toossi et al., 1995). TGF-β is produced in excess 
and is expressed at sites of active Mycobacterium tuberculosis infection (Toossi et al., 
1998).  TGF-β acts by suppressing cell-mediated immunity.  Deactivation of 
macrophages by TGF-β downregulates IFN-γ and TNF-α production.  The generation of 
reactive oxygen intermediates (ROIs) and reactive nitrogen intermediates (RNIs) is also 
inhibited by TGF-β (Toossi et al., 1998).  TGF-β was present in the cellular infiltrate of 
granulomas from patients with active Mycobacterium tuberculosis infection, suggesting 
its involvement in the tissue damage and fibrosis that occurs in cases of tuberculosis 
infection (Toossi et al., 1995). 
Tumor Necrosis Factor Alpha (TNF-α) 
 TNF-α is an important mediator of inflammation during Mycobacterium 
tuberculosis and is believed to play multiple roles in the immune and pathologic 
responses to tubercle bacilli (Flynn et al., 2001).  TNF-α is a proinflammatory cytokine 
produced by macrophages, monocytes, and T cells upon stimulation with mycobacteria or 
mycobacterial products (as reviewed by Flynn et al., 2001).  TNF-α plays a key role in 
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granuloma formation, macrophage activation, and possesses immunoregulatory 
properties (as reviewed by van Crevel et al., 2002).   
Influence of TNF-α on Granuloma Formation and Cytokine Production 
Mice treated with a TNF-α-neutralizing antibody displayed an increase in IFN-γ 
and IL-12 production and inducible nitric oxide synthase gene 2 (NOS2) expression 
within lung granulomas (Chakravarty et al., 2008).  The production of the pro-
inflammatory cytokines IFN-γ and IL-12 increases inflammation within the granulomas, 
defining a possible anti-inflammatory role for TNF-α.  An increased production of the 
anti-inflammatory cytokine IL-10 was also present within the granulomas.  The presence 
of IL-10 was hypothesized to decrease inflammation within the lungs of the TNF-α-
neutralized mice (Chakravarty et al., 2008).    To demonstrate the importance of TNF-α 
in mounting a successful protective immune response against Mycobactrium tuberculosis 
infection, BCG- immunized C57BL/6 mice were treated with TNF-α-neutralizing 
hamster monoclonal antibody one week prior to intravenous infection with 
Mycobacterium tuberculosis.  Results from the experiment revealed that neutralization of 
TNF-α impaired the ability of the mice to control the infection.  Mice with a disruption in 
the gene encoding for the 55kDa TNF receptor   (TNFRp55-/-
 
) were also unable to 
control Mycobacterium tuberculosis infection (Flynn et al., 1995).  Granulomas were 
present in the lungs of both sets of mice; however they were necrotizing and contained an 
overwhelming number of tubercle bacilli (Flynn et al., 1995).  The findings from both 
experiments define the importance of TNF-α in controlling Mycobacterium tuberculosis 
infection.   
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TNF-α-Induced Production of Nitric Oxide (NO.
 It is hypothesized that TNF-α stimulates the production of nitric oxide (NO
) 
.) by 
Mycobacterium tuberculosis-infected alveolar macrophages (Lyons, 1995 as reviewed by 
Rich et al., 1997).  To study the effect of TNF-α on Mycobacterium tuberculosis-infected 
alveolar macrophages, human alveolar macrophages were infected with Mycobacterium 
tuberculosis and incubated with TNF-α or pentoxifylline, a non-specific inhibitor of 
TNF-α.  The results showed that TNF-α alone increased Mycobacterium tuberculosis-
induced NO. production by the alveolar macrophages.  Pentoxifylline inhibited NO. 
production by the alveolar macrophages as expected (Rich et al., 1997).  The results from 
this experiment show that TNF-α is required for NO. 
Role of TNF-α in Macrophage Apoptosis 
production by human alveolar 
macrophages. 
 TNF-α is hypothesized to contribute to the apoptosis of Mycobacterium 
tuberculosis-infected macrophages.  To investigate the role that TNF-α has in inducing 
the apoptosis of Mycobacterium tuberculosis-infected macrophages, alveolar 
macrophages obtained from bronchoalveolar lavage (BAL) of healthy subjects were 
infected with either the attenuated (H37Ra) or virulent (H37Rv) Mycobacterium 
tuberculosis strains.  Following ELISA analysis of TNF-α levels, apoptosis of the 
alveolar macrophages was measured using the TUNEL assay.  Results from the 
experiment showed significant TNF-α-induced apoptosis in both Mycobacterium 
tuberculosis strains compared to the control.  H37Ra however, displayed a higher level of 
TNF-α-induced apoptosis than H37Rv (Balcewicz-Sablinska et al., 1998).    
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Use of TNF-α Blockers 
Systemic spillover of TNF-α can lead to unwanted inflammatory effects such as 
fever, weight loss, tissue necrosis, and systemic shock (as reviewed by Bekker et al., 
1998).  In tuberculosis patients receiving treatment, an increase of TNF-α was observed 
in their plasma and it was accompanied by weight loss and clinical deterioration (Bekker 
et al., 1998).  In order to prevent or limit the deleterious effects of TNF-α, it is necessary 
to downregulate  systemic production of TNF-α and increase soluble TNF-α receptors 
that block TNF-α activity (as reviewed by van Crevel et al., 2002).   
To determine a cause for reduced apoptosis in H37Rv-infected alveolar 
macrophages (Balcewicz-Sablinska et al., 1998), soluble tumor necrosis factor receptor 
(sTNFR), a natural inhibitor of TNF-α, was analyzed for its release during 
Mycobacterium tuberculosis infection.  Results uncovered that there was a six-fold 
increase in the amount of sTNFR present in the supernatant of H37Rv-infected alveolar 
macrophages than the supernatant of H37Ra-infected alveolar macrophages (Fig. 3) 
(Balcewicz-Sablinska et al., 1998).   
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FIG. 3 Higher amount of sTNFR present in the supernatant of H37Rv-infected alveolar macrophages.  
Adapted from Balcewicz-Sablinska et al., 1998 
 
The presence of sTNFR in the supernatant of H37Rv-infected alveolar macrophages was 
responsible for the decrease in TNF-α-induced apoptosis.  Further anaylsis showed that 
increased IL-10 production by the H37Rv-infected macrophages was responsible for the 
accumulation of sTNFR in the supernatant.  The increase in IL-10 inactivated TNF-α.  
When anti-IL-10 antibody was added to the supernatant, sTNFR release was significantly 
reduced and apoptosis was increased (Balcewicz-Sablinska et al., 1998).  Taken together, 
the findings from this experiment suggest a role for IL-10 in regulating the release of 
sTNFR, ultimately controlling TNF-α-induced apoptosis of H37Rv-infected alveolar 
macrophages. 
 Individuals treated with TNF-α blockers contract Mycobacterium tuberculosis 
infection at an increased rate (Saliu et al., 2006).  Three TNF-α-inhibiting drugs that are 
currently being used for the treatment of autoimmune diseases such as rheumatoid 
arthritis are being studied to determine their effect on the macrophage response to 
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mycobacterial infection (Harris et al., 2008).  The three TNF-α-inhibiting drugs, also 
known as TNF-α blockers, currently being used are adalimumab (Humira), infliximab 
(Remicade), and etanercept (Enbrel).  In whole blood samples stimulated with 
Mycobacterium tuberculosis, Humira and Remicade inhibited T cell activation and IFN-γ 
production whereas Enbrel did not (Table 1) (Saliu et al., 2006).  
 
TABLE 1 Tumor-necrosis-factor blockade: effects on T cell activation (in terms of CD69 expression).  
Adapted from Saliu et al., 2006 
 
 The difference in the effect that Enbrel has on T cell activation and IFN-γ production 
suggest that it uses a different mechanism than the one used by Humira and Remicade, 
possibly making it a better drug for the treatment of Mycobacterium tuberculosis 
infection. 
To determine the effect of Humira, Remicade, and Enbrel on phagosome-
lysosome fusion, human monocytes were infected GFP-BCG or PKH67 labeled H37Ra 
and analyzed using confocal microscopy.  In the absence of IFN-γ stimulation none of the 
drugs had an effect on phagosome acidification in BCG-infected monocytes.  However, 
in H37Ra- and H37Rv-infected monocytes pretreated with IFN-γ, Humira, Remicade, 
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and Enbrel all inhibited IFN-γ phagosome acidification (Harris et al., 2008).  In 
macrophages derived from PBMCs, Humira and Remicade inhibited phagosome 
acidification in both untreated and IFN-γ-stimulated cells whereas Enbrel did not (Harris 
et al., 2008).  The difference in the macrophage types may have contributed to the 
differences seen in the actions of the drugs. 
Interferon Gamma (IFN-γ)  
IFN-γ is a cytokine of great importance in controlling Mycobacterium 
tuberculosis infection.  IFN-γ is produced by T cells and NK cells and is required for the 
protective response against Mycobacterium tuberculosis.  The role of IFN-γ in opposing 
survival of tubercle bacilli is to promote phagosome acidification and phagolysosome 
fusion (as reviewed by Salgame, 2005). 
Defective genes for IFN-γ in Mice and Humans 
Humans defective in genes for IFN-γ or the IFN-γ receptor are highly susceptible 
to mycobacterial infections, including Mycobacterium tuberculosis (Jouanguy et al., 1996 
as reviewed by Raja, 2004).  A lack of IFN-γ also poses a threat to the immune response 
of mice.  IFN-γ gene knockout mice infected with the virulent Mycobacterium 
tuberculosis Erdman strain either intravenously or with aerosol were unable to control 
infection, making them highly susceptible to Mycobacterium tuberculosis infection 
(Cooper et al., 1993). 
Implication of IFN-γ in NO.
IFN-γ is hypothesized to be involved in NO
 Production 
. production by activated monocytes.  
In an experiment where Mycobacterium tuberculosis-infected PBMCs were stimulated 
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with IFN-γ, NO. production was significantly increased (Sharma et al., 2004).  The 
finding from this experiment supports the hypothesis that IFN-γ induces NO. production.   
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THE INNATE IMMUNE RESPONSE AGAINST MYCOBACTERIUM 
TUBERCULOSIS 
Apoptosis 
 Apoptosis, also referred to as programmed cell death, is a process that is 
important to the development and maintenance of the immune system (Kelly et al., 2008).  
In the host defense against Mycobacterium tuberculosis, apoptosis promotes microbicidal 
activity in alveolar macrophages in an effort to remove the intracellular macrophage 
niche (as reviewed by Gan et al., 2008).  Macrophage apoptosis may contribute to the 
innate immune system response against Mycobacterium tuberculosis by containing and 
limiting the growth of tubercle bacilli (as reviewed by Kelly et al., 2008) by keeping the 
membrane barrier intact (Gan et al., 2008).  Macrophage necrosis, on the other hand, 
releases viable tubercle bacilli from macrophages for the extracellular spread of infection 
(as reviewed by Gan et al., 2008).  Macrophage necrosis causes cell lysis and death, 
leading to the inflammation that promotes tissue damage.  The act of macrophage 
necrosis is responsible for the recruitment of naïve macrophages that ultimately become 
infected, thus prolonging Mycobacterium tuberculosis infection (Gan et al., 2008).  The 
attenuated H37Ra Mycobacterium tuberculosis strain induces macrophage apoptosis 
while the virulent H37Rv Mycobacterium tuberculosis strain induces macrophage 
necrosis (Fratazzi et al., 1997 as reviewed by Gan et al., 2008). 
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Role of Bystander Apoptosis in Reducing the Spread of Mycobacterium tuberculosis 
In an attempt to uncover how the process of apoptosis occurs in macrophages of 
Mycobacterium tuberculosis-infected patients, Kelly et al. (2008) conducted a series of 
three experiments.  Based on findings from previous studies involving the attenuated 
Mycobacterium tuberculosis strain H37Ra and human macrophage apoptosis, Kelly et al. 
(2008) conducted an experiment that investigated if apoptosis also occurred in uninfected 
bystander macrophages.  Using the TUNEL staining technique, infected and uninfected 
macrophages were co-cultured and observed for apoptosis for 24, 48, and 96h.  Apoptosis 
of infected macrophages was observed 24h postinfection with significant increases in 
apoptosis seen at 48 and 96h postinfection.  The results also showed bystander apoptosis 
in the uninfected macrophages occurring at 48 and 96h postinfection (Fig. 4) (Kelly et al., 
2008). 
 
FIG. 4 Mycobacterium tuberculosis strain H37Ra induces bystander apoptosis in uninfected human 
macrophages.  Adapted from Kelly et al., 2008 
 
To determine if bystander apoptosis of the uninfected macrophages was due to the release 
of soluble factors, supernatant from infected apoptotic macrophages was collected and 
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filtered to remove any mycobacteria.  The supernatant was then added to the uninfected 
macrophages and the level of apoptosis was measured using ELISA.  The results revealed 
that the supernatant did not induce apoptosis in the uninfected macrophages at any 
timepoint (Fig. 5) (Kelly et al., 2008). 
 
FIG. 5 Soluble factors released from infected apoptotic human macrophages do not induce apoptosis in 
uninfected bystander macrophages.  Adapted from Kelly et al., 2008 
 
In a final attempt to determine the cause of bystander apoptosis, the uninfected 
macrophages were labeled with PKH67, a green fluorescent dye that gets incorporated 
into the lipid regions of the plasma membrane, and added to infected macrophages.  The 
cells were co-incubated for 24 and 48h then stained using TUNEL TMR (red) to 
determine if cell-cell contact was required for bystander apoptosis to occur.  Bystander 
macrophages undergoing apoptosis were labeled with red-green stains, showing an 
increase in the level of bystander apoptosis in uninfected macrophages (Fig. 6).   
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FIG. 6 Cell-cell contact between infected and uninfected macrophages induces bystander apoptosis.  
Adapted from Kelly et al., 2008 
 
The results from the experiment showed that cell-cell contact between the infected and 
uninfected macrophages induced significant bystander apoptosis.  Bystander apoptosis 
may be a mechanism used by the innate immune response to mediate the killing of 
uninfected potential niche cells, an occurrence that may serve as a way to control and 
limit the progression of Mycobacterium tuberculosis infection (Kelly et al., 2008). 
Inducible Nitric Oxide Synthase (iNOS) and Nitric Oxide (NO.
 Reactive nitrogen intermediates (RNIs) are antimicrobial agents formed by 
)   
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macrophages (as reviewed by Miller et al., 2004).  RNIs are produced by inducible nitric 
oxide synthase (iNOS) and gives rise to NO. (Miller et al., 2004).  NO. is one of the few 
bactericidal agents produced in vivo that is capable of successfully killing Mycobacterium 
tuberculosis.  NO. is a highly active free radical that is both lipid and water soluble and 
has the ability to react with oxygen and oxygen intermediates to yield mycobactericidal 
products such as NO2, NO2-, NO3-, N2O3, and ONOO-
Determination of iNOS Recruitment to Phagosomes with the Use of Latex Beads 
 (as reviewed by Davis et al., 
2007). 
Mycobacterium tuberculosis has the ability to disrupt iNOS recruitment to 
phagosomes (Davis et al., 2007; Miller et al., 2004).  In testing the recruitment of iNOS 
to phagosomes, it is important that the alveolar macrophages are stimulated and ready to 
battle infection.   In studies conducted by Davis et al. (2007) and Miller et al. (2004) 
alveolar macrophages were stimulated with IFN-γ and lipopolysaccharide (LPS) prior to 
infection with mycobacteria.  In the study conducted by Miller et al. (2004) mouse 
macrophages were infected with IgG coated latex beads and incubated with polyclonal 
rabbit anti-iNOS antibody.  Using immunofluorescence microscopy, the intracellular 
recruitment of iNOS to phagosomes infected with mycobacteria was examined.  The 
results revealed that the latex bead phagosomes recruited iNOS, while iNOS recruitment 
to mycobacterial phagosomes did not occur because of the mycobacteria (Fig. 7) (Miller 
et al., 2004 ).   
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FIG. 7 Latex bead phagosomes recruit iNOS but  phagosomes containing mycobacteria do not.  J774 
macrophages (A and B).  Bone marrow-derived macrophages (C and D).  Adapted from Miller et al., 
2004 
 
Using immunofluorescence laser scanning confocal microscopy, Davis et al. (2007) 
compared iNOS recruitment of phagosomes containing live mycobacteria to that of 
phagosomes containing heat-killed mycobacteria.  The results revealed that phagosomes 
containing live mycobacteria had a reduction in iNOS recruitment when compared to 
latex bead phagosomes, while phagosomes containing heat-killed mycobacteria had no 
effect on iNOS recruitment to phagosomes (Fig. 8). Taken together, these results suggest 
that recruitment of iNOS to mycobacteria containing phagosomes is only inhibited in 
alveolar macrophages harboring live mycobacteria (Davis et al., 2007). 
24 
 
 
FIG. 8 Live mycobacteria reduces iNOS recruitment to phagosomes.   (A) Localization of iNOS 
(green/red) to the phagosome for latex beads (red) and dead mycobacterial phagosomes (red), but not in 
live mycobacterial phagosomes (green). (B) iNOS localization to phagosomes in macrophages  infected 
with latex beads, live, or dead mycobacteria.  Adapted from Davis et al., 2007 
 
The Actin Cytoskeleton and iNOS Recruitment  
 It was once believed that iNOS was diffusely distributed in the cytosol of 
phagosomes but recently it has been recognized that iNOS recruitment to phagosomes 
within alveolar macrophages requires a functional actin cytoskeleton.  Ezrin-radixin-
moesin (ERM)-binding phopshoprotein 50 (EBP50) is a protein that belongs to a family 
of membrane-cytoskeleton linking proteins.  EBP50 interacts with the CD44 glycoprotein 
located at the actin filament-plasma membrane interaction site.  The interaction of EBP50 
with CD44 allows EBP50 to anchor different proteins to the actin cytoskeleton. Activated 
mouse alveolar macrophages transfected with GFP-labeled EBP50 were infected with 
Texas-Red-labeled latex beads and stained for iNOS.  Using fluorescence microscopy, 
the localization of iNOS to the latex bead phagosomes was analyzed.  The results from 
the experiment showed an increase in iNOS recruitment to the latex bead phagosomes.  
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However, when the mouse macrophages were transfected with a short interfering RNA 
(siRNA) sequence directed against EBP50,  iNOS recruitment to the latex bead 
phagosomes decreased.  These findings show that EBP50 is in fact required for iNOS 
recruitment to phagosomes (Fig. 9) (Davis et al., 2007).   
  
FIG. 9 EBP50 is required for  iNOS recruitment to latex bead phagosomes.  (B) iNOS recruitment using 
EBP50. (D) iNOS recruitment using EBP50 siRNA.  Adapted from Davis et al., 2007 
 
Coronin-1 is an actin-associated protein that functions in the rearrangement of actin.  
Coronin-1 is important for cell motility and phagocytosis.  Mouse macrophages 
transfected with coronin-1 siRNA and incubated with Alexa 568-labeled latex beads 
showed a significant increase in iNOS recruitment to the LB phagosomes (Fig. 10) 
(Davis et al., 2007).  
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FIG. 10 siRNA against coronin-1 increases iNOS recruitment to latex bead phagosomes.  Adapted from 
Davis et al., 2007 
 
 Miller et al. (2004) utilized the actin microfilament disrupter cytochalasin D and the 
actin microfilament stabilizer, jasplakinolide, to show that they cause a decrease in iNOS 
recruitment to latex bead phagosomes.  Cytochalasin D is a membrane permeable peptide 
that has the ability to bind to actin filaments and prevent their polymerization and 
elongation.  Jasplakinolide is a membrane permeable peptide that participates in actin 
polymerization and actin filament stabilization.  When cytochalasin D treatment was 
followed by jasplakinolide, iNOS recruitment to latex bead phagosomes was comparable 
to the control (Fig. 11) (Miller et al., 2004).   
 
FIG. 11 A functional actin cytoskeleton is necessary for iNOS recruitment to phagosomes.  Adapted from 
Miller et al., 2004 
 
Taken together, these findings clearly suggest that interfering with actin microfilament 
motility can disrupt the recruitment of iNOS to latex bead phagosomes and that it is 
necessary to have a functional actin cytoskeleton in order to ensure iNOS recruitment to 
phagosomes (Miller et al., 2004). 
Taking their experiment a step further, Davis et al. (2007) performed immuno- 
fluorescence laser scanning confocal microscopy to test iNOS recruitment to 
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mycobacterial phagosomes using EBP50 and coronin-1.  Macrophages transfected with 
siRNA against EBP50 followed by phagocytosis of Alexa-568 labeled dead mycobacteria 
showed a decrease in iNOS recruitment, demonstrating that a mutation in EBP50 alters 
iNOS recruitment to mycobacteria- infected alveolar macrophages (Fig. 12).   
 
 
FIG. 12 Mutations in EBP50 alters iNOS recruitment to mycobacteria-infected phagosomes.  Adapted 
from Davis et al., 2007 
 
When macrophages were transfected with a siRNA against coronin-1 and incubated with 
Alexa-568 labeled live mycobacteria, no effect on iNOS recruitment to phagosomes 
containing live mycobacteria was observed (Fig. 13). 
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FIG. 13 Mutations in coronin-1does not increase iNOS recruitment to mycobacteria-infected phagosomes.  
Adapted from Davis et al., 2007 
 
This finding shows that coronin-1 has no role in mycobacteria-induced inhibition of 
iNOS recruitment to mycobacteria-infected phagosomes (Davis et al., 2007). 
Mouse Model of iNOS Recruitment 
 Variability in the sensitivity of different Mycobacterium tuberculosis strains is 
hypothesized to affect the ability of RNIs to limit the growth and replication of 
Mycobacterium tuberculosis (Scanga et al., 2001).  To test this possibility, three 
anonymous clinical isolates of Mycobacterium tuberculosis from patients harboring 
active infection and the laboratory Mycobacterium tuberculosis Erdman strain were used 
to test the importance of iNOS-mediated effector functions.  C57BL/6 mice and iNOS 
gene-disrupted mice (NOS2-/-) were infected either intravenously or with aerosol 
containing the different Mycobacterium tuberculosis strains.  The results showed the 
three clinical strains and Erdman strain growing at a higher rate in the NOS2-/- mice 
following intravenous infection than in the C57BL/6 wild-type mice (Fig. 14) (Scanga et 
al., 2001).   
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FIG. 14 NOS2-/- mice have a higher bacterial burden in the lungs following intravenous infection.  NOS2-/-
 
 
mice (closed circles).  Wild-type C57BL/6 mice (open circles) mice.  Mycobacterium tuberculosis strains: 
(A) Erdman (B-D) Anonomyous clinical isolates.  Adapted from Scanga et al., 2001  
The NOS2-/-
 
 mice also had a higher bacterial burden in their lungs following aerosol 
infection with the clinical and Erdman Mycobacterium tuberculosis strains (Fig. 15) 
(Scanga et al., 2001).   
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FIG. 15 NOS2-/- mice have a higher bacterial burden in the lungs following aerosol infection.  NOS2-/-
 
 
mice (closed circles).  Wild-type C57BL/6 mice (open circles) mice.  Mycobacterium tuberculosis strains: 
(A) Erdman  (B-D) Anonomyous clinical isolates.  Adapted from Scanga et al., 2001  
Without the ability to produce iNOS, the mice quickly succumbed to infection regardless 
of the route of administration.  The results from these experiments display the importance 
of iNOS in controlling Mycobacterium tuberculosis infection.   
To investigate the role of the adaptive immune response in host resistance to 
Mycobacterium tuberculosis, C57BL/6 mice and NOS2-/- were infected with H37Rv or 
H37Ra in aerosol and observed for their CD4+ and CD8+
 
 T cell responses.   The number 
of infiltrating leukocytes into the lungs of both sets of mice was similar to one another at 
day 14 and day 30 postinfection (Fig. 16) (Beisiegel et al., 2009).   
FIG. 16 NOS2-/-
 
 mice and wild-type C57BL/6 mice have a similar amount of leukocyte infiltration.  
Adapted from Beisiegel et al., 2009  
Of the infiltrating leukocytes, CD4+ T cell numbers were higher than CD8+ T cell 
numbers in both sets of mice (Fig. 17).   
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FIG. 17 NOS2-/- mice and wild-type C57BL/6 mice have a higher number of infiltrating CD4+
 
 T cells into 
the lungs.  Adapted from Beisiegel et al., 2009  
Further investigation revealed that the CD4+ and CD8+
 
 T cells predominately produced 
IFN-γ and TNF-α with negligible IL-17 production (Fig. 18) (Beisiegel et al., 2009).   
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FIG. 18 CD4+ and CD8+ T cells of NOS2-/-
 
 and wild-type C57BL/6 mice predominately produce IFN-γ and 
TNF-α with negligible IL-17 production.   Adapted from Beisiegel et al., 2009  
This study shows that NOS2-/-
Human Study of iNOS Expression 
 mice are capable of mounting an adaptive immune 
response comparable to wild-type control mice upon challenge with Mycobacterium 
tuberculosis.  
 
 The production of NO. by Mycobacterium tuberculosis-infected mouse alveolar 
macrophages has led to the hypothesis that human Mycobacterium tuberculosis-infected 
alveolar macrophages are also capable of producing NO..  Supernatant from 
Mycobacterium tuberculosis-infected human alveolar macrophages showed an 
accumulation of NO.
 
 that could be inhibited in a dose-dependent manner when an iNOS 
inhibitor was used (Fig. 19).  
FIG. 19 iNOS inhibitor can inhibit NO.
 
 production in human alveolar macrophages in a dose-dependent 
manner.  Adapted from Rich et al., 1997  
The use of the iNOS inhibitor increased the bacterial burden in the Mycobacterium 
tuberculosis-infected alveolar macrophages (Rich et al., 1997).  The results from this 
specific experiment demonstrate that human Mycobacterium tuberculosis-infected 
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alveolar macrophages are capable of producing NO. and that this production of NO.
iNOS expression and generation of RNIs by alveolar macrophages of patients 
harboring active Mycobacterium tuberculosis infection was hypothesized to be detectable 
through an increased level of exhaled NO
 is 
important for inhibiting the growth of Mycobacterium tuberculosis. 
..  Wang et al. (1998) conducted a study that 
measured the level of NO. exhaled by patients with active infection.  Patients with active 
Mycobacterium tuberculosis infection exhaled significantly higher levels of NO. than 
healthy control subjects.  iNOS expression by the alveolar macrophages of the 
tuberculosis patients was significantly higher than the control subjects and correlated 
with the level of NO. 
 
that was exhaled (Fig. 20) (Wang et al., 1998).   
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FIG. 20 Increased iNOS expression by alveolar macrophages of tuberculosis patients correlates with 
increased NO. exhalation.  Top figure: Level of iNOS expression.  Bottom figure: Concentration of exhaled 
NO.
 
;TB patients (open circles); Control subjects (closed circles).  Adapted from Wang et al., 1998 
Confirming these findings, BAL supernatant from the tuberculosis patients contained 
levels of nitrite that was significantly higher than the nitrite levels observed in the control 
subjects.  Upon further investigation, cultured alveolar macrophages from tuberculosis 
patients showed a spontaneous release of nitrite in culture medium at a greater extent than 
that released by control subjects (Fig. 21) (Wang et al., 1998).   
 
FIG. 21 Alveolar macrophages from tuberculosis patients show a higher release of nitrite than control 
subjects.  Adapted from Wang et al., 1998 
 
Overall, the finding from this study supports the hypothesis that an increase in exhaled 
NO.
Toll-Like Receptors (TLRs) 
 results from increased expression of iNOS by alveolar macrophages. 
 The first step in mounting an effective host response against Mycobacterium 
tuberculosis begins with innate recognition of mycobacterial products.  The purpose of 
the innate immune system is to mount a rapid protective response during the early phase 
of infection while instructing adaptive T cell-mediated immune responses during the later 
phase of infection (Medzhitov et al., 2000 as reviewed by Branger et al., 2004).  TLRs 
are activated immediately upon or shortly after the uptake of Mycobacterium tuberculosis 
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by macrophages (Heldwein et al., 2002) which make their successful activation one of 
vital importance. 
 The Toll-like receptor was first studied in the fruit fly, Drosophila melanogaster.  
Through the study of Drosophila melanogaster TLR proteins, mammalian homologues 
were discovered.  The human homologue of the Drosophila melanogaster Toll protein is 
Toll-like receptor 4 (TLR4).  There are three features of the Toll protein that link it with 
innate immunity.  The first feature is its participation in antifungal responses.  The second 
feature is its participation in signal transduction pathways.  The similarity between the 
Drosophila melanogaster Toll protein and mammalian homologues is that the Drosophila 
melanogaster Toll protein leads to the activation of the transcription factor Dorsal, the fly 
homologue of NF-κB in mammals that signals cytokine production.  The final feature 
refers to the similar intracellular domains that the Drosophila Toll protein and 
mammalian TLRs share (as reviewed by Means et al., 1999). 
Mycobacterial Antigens Recognized by TLRs 
To mount a successful response against mycobacterial infection TLRs must be 
able to recognize and process mycobacterial antigens.  Three common antigens known to 
trigger a response in the event of Mycobacterium tuberculosis infection are 19kDa 
lipoprotein, lipoarabinomannan (LAM), and soluble tuberculosis factor (STF). 
19kDa Lipoprotein 
 19kDa lipoprotein is a bacterial lipoprotein that belongs to a group of molecules 
possessing pathogen-associated molecular patterns.  The pathogen-associated molecular 
patterns present in this group of molecules contain molecular motifs that are found in 
microorganisms, not mammalian hosts (Stenger et al., 2002).  19kDa lipoprotein is an 
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antigen secreted by Mycobacterium tuberculosis and is a potent inducer of TH1 and 
cytolytic T cell responses through the induction of IL-12 (Brightbill et al., 1999).  19kDa 
lipoprotein induced IL-12 release in both mouse and human macrophages.  The 
interaction of 19kDa lipoprotein with TLR2 shows that it is capable of inducing NO.
 Lipoarabinomannan (LAM) 
 
production in mouse macrophages (Brightbill et al., 1999).  
 LAM is a glycolipid found in the walls of mycobacteria and plays a key role in 
triggering cytokine secretion by macrophages.  LAM is a potent inducer of TNF-α in both 
mouse and human macrophages (Moreno et al., 1989).  LAM activates mouse 
macrophages by interacting with the cell surface molecule CD14 (Means et al., 1999).  
Through the interaction of LAM with CD14, an intracellular signal is generated by TLR2 
to activate macrophages (Means et al., 1999). 
Soluble Tuberculosis Factor (STF) 
 STF is a short-term-culture filtrate of Mycobacterium tuberculosis that contains 
the mycobacterial glycolipid phosphatidylinositolmannan (PIM).  PIM induces TNF-α 
secretion by mouse macrophages.  STF is similar to both 19kDa lipoprotein and LAM in 
that it only interacts with TLR2, not TLR4 (Jones et al., 2001). 
Role of Myeloid Differentiation Protein 88 (MyD88) in TLR Signal Transduction 
 Signal transduction by TLRs is necessary for carrying out an effective innate 
immune response.  Proper signal transduction in most TLRs require myeloid 
differentiation protein 88 (MyD88) (as reviewed by Tjarnlund et al., 2006).  MyD88 is an 
adaptor molecule that links TLR recognition to the activation of interleukin (IL)-1/ IL-1 
receptor-associated kinase (IRAK), a factor essential for Mycobacterium tuberculosis-
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induced activation of macrophages (as reviewed by van Crevel et al., 2002).   Multiple 
studies reviewed by Tjarnlund et al. (2006) showed that mice deficient in MyD88 failed 
to generate any proinflammatory responses when stimulated through their TLRs, leaving 
them highly susceptible to mycobacterial infections. 
Control of Mycobacterium tuberculosis Infection by TLR2 and TLR4 
 TLR2 and TLR4 have both demonstrated the ability to mediate Mycobacterium 
tuberculosis-induced intracellular signaling in vitro and are therefore the TLRs of interest 
(Branger et al., 2004).  The mouse types used for the TLR studies were the C3H/HeJ 
(TLR4-defective) mouse and its control C3H/HeN (TLR4-competent) mouse as well as 
the C57BL/6 (TLR2-competent) and BALB/c (CD14-competent) mouse.  In a study 
conducted by Reiling et al. (2002) mice deficient in CD14, TLR2, and TLR4 were 
administered 100 CFU of Mycobacterium tuberculosis aerosol.  All three sets of mice 
contained bacterial loads in their lungs similar to those of their control mice at 105 days 
postinfection (Fig. 22) (Reiling et al., 2002). 
 
FIG. 22 TLR2 and TLR4 are not effective alone, they require aid from other innate immune components. 
Control (closed circle) and deficient mice (open circle).  Adapted from Reiling et al., 2002 
 
The results showed that neither TLR2 nor TLR4 were effective in providing a significant 
innate immune response by themselves but that they require aid from other innate 
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immune components for a successful immune response when challenged with 
Mycobacterium tuberculosis.  In a study conducted by Tjarnlund et al. (2006), TLR2 and 
TLR4 knockout mice and C57BL/6 wild-type mice were also infected with 
Mycobacterium tuberculosis aerosol.  The results showed the bacterial growth in the 
lungs of both the TLR2 and TLR4 knockout mice to be significantly higher during the 
early phase, 3 weeks postinfection, in comparison to the C57BL/6 wild-type mice.  
However, during the later phase, 8 weeks postinfection, there were no differences 
between the three groups of mice (Fig. 23) (Tjarnlund et al., 2006). 
 
 
FIG. 23 TLR2/4-deficient mice display increased susceptibility to aerosol infection with Mycobacterium 
tuberculosis H37Rv.  Adapted from Tjarnlund et al., 2006 
 
To test the importance of TLR4 in preventing the advancement of tuberculosis infection, 
C3H/HeJ mice were administered 100 CFU aerosol of Mycobacterium tuberculosis and 
observed for 250 days.  All of the C3H/HeJ mice died between 160 and 200 days post-
infection (Fig. 24) (Abel et al., 2002).   
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FIG. 24 Reduced survival of the TLR4 mutant C3H/HeJ mice after Mycobacterium tuberculosis H37Rv 
infection.  Wild-type C3H/HeN mice (open circles).  TLR4 mutant C3H/HeJ mice (filled circles).  
Adapted from Abel et al., 2002 
 
A similar fifteen week study conducted by Branger et al. (2004) showed similar results 
when seven of twelve C3H/HeJ mice administered a 100 CFU aerosol of Mycobacterium 
tuberculosis  died and all of the C3H/HeN wild-type mice survived (Fig. 25).  The 
findings from both experiments suggest an important role for TLR4 during the later phase 
of Mycobacterium tuberculosis infection. 
 
FIG. 25 Decreased survival time of TLR4 mutant C3H/HeJ mice following aerosol infection with 
Mycobacterium tuberculosis H37Rv.   Adapted from Branger et al., 2004 
 
An experiment performed by Drennan et al. (2004) spanning a 6 month period tested the 
ability of TLR2-deficient mice to control Mycobacterium tuberculosis infection.  The 
mice were administered 100 CFU of Mycobacterium tuberculosis aerosol and survived 
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the entire 6 month experimental period.  This finding indicates that TLR2 has a different 
way of combating Mycobacterium tuberculosis infection than the one used by TLR4. 
 In separate experiments, higher doses of Mycobacterium tuberculosis were 
administered by aerosol to the mice to determine if an increased dose of aerosol could 
further affect the function of TLRs.  In a second experiment performed by Reiling et al. 
(2002), a higher dose of Mycobacterium tuberculosis aerosol was administered to both 
C3H/HeJ and TLR2-deficient mice.  Both sets of mice were administered a 2000 CFU 
inoculum of Mycobacterium tuberculosis aerosol and were monitored for 210 days.  The 
C3H/HeJ mice were as resistant to the high-dose Mycobacterium tuberculosis infection 
as their C3H/HeN control mice while the TLR2-deficient were significantly more 
susceptible to the high-dose aerosol infection than the C57BL/6 mice (Fig. 26). 
 
   
FIG. 26 TLR2-deficient mice are significantly more susceptible to high dose aerosol infection than TLR4 
mutant C3H/HeJ mice.  Adapted from Reiling et al., 2002 
 
When TLR2-deficicent mice were administered a 500 CFU inoculum of Mycobacterium 
tuberculosis aerosol in an experiment conducted by Drennan et al. (2004), the mice began 
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to die between 7 and 11 weeks postinfection and were all dead by week 22.  C57BL/6 
mice administered the same infectious dose remained healthy and survived the entire 10 
month experimental period.  Data collected from the experiment showed the number of 
viable mycobacteria in the lungs of the TLR2-deficient mice to be highest between week 
8 and 13 postinfection.  In a 23 week study conducted by Branger et al. (2004) the same 
500 CFU aerosol dose was administered to C3H/HeJ mice and all of the mice died (Fig. 
27). 
 
  
FIG. 27 TLR4 mutant C3H/HeJ mice are susceptible to high dose aerosol infection.  Adapted from 
Branger et al., 2004 
 
Because of the differences in the survival rates between the C3H/HeJ and C3H/HeN mice 
Branger et al.(2004) went a step further and conducted an experiment to determine 
whether bacterial loads in the mice differed during the early phase of infection.  The 
lungs of both the C3H/HeJ and C3H/HeN mice were observed at 2 and 5 weeks 
postinfection.  At 2 weeks postinfection, the lungs of the C3H/HeJ mice contained more 
viable mycobacteria than the C3H/HeN mice and at 5 weeks postinfection the lungs of 
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the C3H/HeJ mice displayed a 2.8-fold increase of mycobacteria in their lungs (Fig. 28) 
(Branger et al., 2004). 
 
 
FIG. 28 The lungs of TLR4 mutant C3H/HeJ mice contain more viable bacteria at both 2 and 5 weeks 
postinfection.  Adapted from Branger et al., 2004 
 
Histological Analyses of Mice Lacking TLR4 
 To gain a visual understanding of the damage done to the lungs of mice lacking 
TLR4 during Mycobacterium tuberculosis infection, Branger et al. (2004) performed a 
histopathological analysis of the lungs of C3H/HeJ and C3H/HeN mice at 2 and 5 weeks 
following aerosol infection.  At 2 weeks postinfection, the lungs of the C3H/HeN mice 
displayed a slight cell infiltration consisting of macrophages, lymphocytes and 
neutrophils (Fig. 29a) while the C3H/HeJ mice displayed larger areas of inflammation 
(Fig. 29b) that was attributed to the higher number of leukocytes (Table 2).  At 5 weeks 
postinfection, inflammation was more pronounced in both the C3H/HeN and C3H/HeJ 
mice.  The inflammatory infiltrate of the C3H/HeN mice consumed between 50 and 60% 
of their lung surface (Fig. 29c) (Table 2) and the infiltrate of the C3H/HeJ mice 
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consumed between 70 and 80% of their lung surface (Fig. 29d)      (Table 2) (Branger et 
al., 2004). 
 
 
FIG. 29 Histopathological analysis of the lungs of C3H/HeJ and C3H/HeN mice at 2 and 5 weeks 
postinfection.  (A) Wild-type lung tissue 2 weeks postinfection. (B) TLR4 mutant lung tissue 2 weeks 
postinfection. (C) Wild-type mouse lungs 5 weeks postinfection. (D) TLR4 mutant lungs 5 weeks 
postinfection.  Adapted from Branger et al., 2004 
 
 
TABLE 2   Cell subsets in the left lung in TLR4 mutant and wild-type mice during pulmonary 
tuberculosis.  Adapted from Branger et al., 2004 
 
Abel et al. (2002) also studied the inflammatory responses in the lungs of C3H/HeJ and 
C3H/HeN mice exposed to Mycobacterium tuberculosis aerosol.  Microscopy of the 
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lungs of both the C3H/HeJ and C3H/HeN mice 28 days postinfection showed the 
formation of small granulomas (Fig. 30a; Fig. 30b).  At 140 days postinfection the 
C3H/HeJ mice had massive inflammation in their lungs with large numbers of 
macrophages and neutrophils consuming majority of the airspace (Fig. 30d) while the 
C3H/HeN mice did not (Fig. 30c) (Abel et al., 2002).  
 
FIG. 30 The inflammatory responses in the lungs of both C3H/HeJ and C3H/HeN mice exposed to 
Mycobacterium tuberculosis aerosol.   (A) C3H/HeN and (B) C3H/HeJ mice 28 days following aerosol 
infection.  (C) C3H/HeN and (D) C3H/HeJ mice 140 days following aerosol infection.  Adapted from 
Abel et al., 2002 
 
To further investigate the inflammatory cells recruited to the lungs of the mice during the 
inflammatory response, BAL was performed 4 weeks following aerosol infection with 
Mycobacterium tuberculosis.  The results showed comparable total cell counts for the 
two groups of mice, however the C3H/HeN mice had a significantly larger proportion of 
macrophages present than the C3H/HeJ mice (Fig. 31a).  Besides the number of 
macrophages present in the two groups of mice, the lymphocyte population was also 
comparable (Fig. 31b).  BAL analysis showed a significant number of neutrophils being 
recruited to the lungs of the C3H/HeJ mice but not the C3H/HeN mice (Fig. 31c).  The 
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data obtained from this experiment support the histological findings of reduced 
macrophage but significant neutrophil recruitment to the lungs of C3H/HeJ mice 
harboring Mycobacterium tuberculosis infection (Abel et al., 2002). 
 
FIG. 31 Decreased macrophage and increased neutrophil recruitment into the lungs of TLR4 mutant 
C3H/HeJ mice 4 weeks postinfection.  Adapted from Abel et al., 2002 
 
TLR2- and TLR4-Mediated Cytokine Production 
 
 After observing how a lack of TLR2 and/or TLR4 could affect cell recruitment to 
the lungs of Mycobacterium tuberculosis-infected mice, Reiling et al. (2002) compared 
the production of IL-12 in TLR2-deficient and C3H/HeJ mice in a 10 day study to 
determine if a lack in cell recruitment placed a damper on important cytokine production.  
There were no significant differences observed in IL-12 production between the C3H/HeJ 
and C3H/HeN mice at day 0 or day 10 postinfection (Fig. 32a).  The TLR2-deficient 
mice however showed a significant decrease in the IL-12 production in comparison to 
C57BL/6 mice at day 10 (Fig. 32b).  This difference in IL-12 production at day 10 is 
hypothesized to be responsible for the TLR2-deficient mices’ higher susceptibility to 
Mycobacterium tuberculosis infection and decreased proinflammatory response (Reiling 
et al., 2002). 
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FIG. 32 IL-12 production in C3H/HeJ and TLR2-deficient mice following high-dose aerosol infection with 
Mycobacterium tuberculosis.  Adapted from Reiling et al., 2002 
 
Abel et al. (2002) also conducted an experiment to observe cytokine production in the 
lungs of C3H/HeJ mice following Mycobacterium tuberculosis infection.  At 4 weeks 
postinfection, BAL fluid of C3H/HeJ mice was assessed using ELISA.  The results 
showed a significant reduction in IL-12 production (Fig. 33a) while TNF-α and IFN-γ 
production remained steady (Fig. 33b; Fig. 33c). 
 
FIG. 33 Decreased IL-12 production in BAL fluid of TLR4 mutant C3H/NeJ mice following 
Mycobacterium tuberculosis infection.  (A) IL-12p40, (B) IFN-γ, (C) TNF-α.  Adapted from Abel et al., 
2002 
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To further assess cytokine production in the C3H/HeJ mice, the infected lungs were 
homogenized and the supernatants were analyzed.  The results once again showed a 
significant reduction in both IL-12 and TNF-α (Fig. 34a; Fig. 34c) while the level of IFN-
γ was only slightly lower than the C3H/HeN mice (Fig. 34b).  The results from this study 
suggest that the reduction in proinflammatory cytokines upon Mycobacterium 
tuberculosis infection is associated with an increased susceptibility to Mycobacterium 
tuberculosis infection (Abel et al., 2002). 
  
FIG. 34 Decreased cytokine levels in the lungs of TLR4 mutant C3H/HeJ mice.  (A) IL-12, (B) IFN-γ, (C) 
TNF-α.  Adapted from Abel et al., 2002  
 
IFN-γ production in C3H/HeJ mice following aerosol infection with Mycobacterium 
tuberculosis displayed similar IFN-γ levels to C3H/HeN mice at 2 weeks postinfection.  
At 5 weeks postinfection, however, IFN-γ levels in the C3H/HeJ mice were elevated (Fig. 
35), coinciding with the increased mycobacterial load observed in their lungs (Branger et 
al., 2004).   
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FIG. 35 IFN-γ concentrations in lungs of TLR4 mutant C3H/HeJ and wild-type mice following aerosol 
infection with Mycobacterium tuberculosis.   Adapted from Branger et al., 2004 
 
In the case of TLR2 and TLR4 knockout mice, mRNA expression of both IFN-γ and 
TNF-α were the same as the wild-type mice at both 3 and 8 weeks postinfection 
(Tjarnlund et al., 2006). 
Gamma Delta (γδ) T Cells 
 γδ and CD4+ cells are the two dominant T cell subsets found in the human 
immune response to Mycobacterium tuberculosis that contribute to the proinflammatory 
responses involved in protective immunity (Tsukaguchi et al., 1999).  In normal healthy 
individuals, there are more Mycobacterium tuberculosis-reactive γδ T cells than αβ T 
cells.  All γδ T cells express a TCR encoded by a single Vγ9 and Vδ2 gene (as reviewed 
by Li et al., 1998) and studies have shown that γδ T cells are the main source of IFN-γ 
production (Tsukaguchi et al., 1999).  Li et al. (1998) showed that patients harboring 
active tuberculosis infection have a significantly reduced number of Mycobacterium 
tuberculosis-reactive γδ T cells in their blood and BAL in comparison to normal healthy 
individuals.  This finding may explain the progression and severity of Mycobacterium 
tuberculosis disease.  The loss or absence of γδ T cells in tuberculosis patients may 
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reflect anergy, inactivation or dysfunction of immune cell populations necessary for γδ T 
cell activation and growth, or activation-induced cell death (AICD) (as reviewed by Li et 
al., 1998). 
Effect of Drug Chemotherapy on γδ T Cell Numbers 
 As drug treatment for patients harboring active Mycobacterium tuberculosis 
infection evolves, a question of whether or not drug chemotherapy is responsible for the 
decreased numbers of Mycobacterium tuberculosis-reactive γδ T cells in tuberculosis 
patients remains unclear.  In an attempt to determine if drug chemotherapy adversely 
affects γδ T cells or has a beneficial effect on γδ T cell numbers, Li et al. (1998) 
conducted an experiment to analyze the number of peripheral γδ T cells during and after 
drug chemotherapy.  The results from the study showed a significant reduction in the γδ 
T cell numbers of non-treated active disease patients in comparison to the γδ T cell 
numbers of non-treated normal patients.  Non-treated patients with inactive (latent) 
disease showed a slight decrease in their γδ T cell numbers in comparison to non-treated 
normal patients but showed a significant increase in their γδ T cell numbers in 
comparison to non-treated patients with active disease (Fig. 36) (Li et al., 1998).  
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FIG. 36 Tuberculosis patients with active disease have reduced numbers of Mycobacterium tuberculosis-
reactive γδ T cells.  Adapted from Li et al., 1998 
 
 All of the active and inactive disease patients and normal patients undergoing drug 
treatment were followed for a period of time spanning from 2 to 16 months.  The treated 
active disease patients had a decrease in their γδ T cell numbers despite the length of 
treatment.  γδ T cell numbers were recovered in the treated inactive (latent) disease 
patients (Fig. 36).  Based on the results received from the treated groups of patients, it 
was concluded that drug chemotherapy treatment for Mycobacterium tuberculosis was 
not responsible for the loss of γδ T cell numbers in patients harboring active 
Mycobacterium tuberculosis infection (Li et al., 1998). 
 γδ T Cells vs. CD4+
γδ T cells and CD4
 T Cells: IFN-γ Production 
+ T cells produce IFN-γ and serve as cytotoxic effector cells in 
response to Mycobacterium tuberculosis-infected macrophages. To test IFN-γ production 
by γδ T cells and CD4+ T cells in response to Mycobacterium tuberculosis infection, 
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supernatant from human PMBCs were stimulated with either Mycobacterium 
tuberculosis or PPD and analyzed using ELISA and ELISPOT.  CD4+ T cells produced 
IFN-γ in response to PPD and Mycobacterium tuberculosis, while γδ T cells produced 
IFN-γ in response to Mycobacterium tuberculosis only (Fig. 37) (Tsukaguchi et al., 
1999).  The findings from this experiment suggest that CD4+ T cells and  γδ T cells differ 
in the mycobacterial antigens that they recognize.  Findings from the experiment also 
suggest that γδ T cells are capable of producing more IFN-γ on a per cell basis than CD4+
FIG. 37 Comparison of IFN-γ production by CD4
 
T cells in response to tubercle bacilli (Fig. 37) (Tsukaguchi et al., 1999).   
 
+
 
 and γδ T cells in response to Mycobacterium 
tuberculosis.   Adapted from Tskaguchi et al., 1999 
TNF-α plays a role in protective immunity against mycobacterial infections in both mice 
and humans (as reviewed by Tsukaguchi et al., 1999).  To determine the role of γδ T cells 
and CD4+ T cells in TNF-α production, the supernatant from Mycobacterium 
tuberculosis-infected human monocytes in both the presence and absence of γδ T cells 
and CD4+ T cells was analyzed using ELISA.  Results from the experiment revealed that 
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TNF-α is increased in the presence of γδ T cells and CD4+ 
Influence of NK Cells on γδ T Cell Numbers 
T cells (Tsukaguchi et al., 
1999). 
NK cells are effective regulators of the innate and adaptive immune responses.  
The participation of NK cells in the early immune response to intracellular pathogens has 
been recognized.  NK cells are capable of direct cell lysis, IFN-γ production, and 
initiation of apoptosis (as reviewed by Brill et al., 2001).  Isolated human NK cells added 
to Mycobacterium tuberculosis-infected monocytes mediated the killing of intracellular 
tubercle bacilli within 24h of coculture (Brill et al., 2001), demonstrating the effector  
function of this cell type.   Because the relationship between NK and γδ T cell numbers in 
active tuberculosis infection has not been studied, Zhang et al. (2006) hypothesized that 
NK cells might be involved in the immune regulation of γδ T cells in response to 
Mycobacterium tuberculosis and that the loss of γδ T cells may be due to a decrease in 
NK cell activity.  To investigate the role of NK cells in the immune response of γδ T cells 
to Mycobacterium tuberculosis infection, heat-treated antigens from Mycobacterium 
tuberculosis were used to expand γδ T cells in vitro.  Results from the experiment 
showed that γδ T cells proliferate faster in a high NK cell-percentage population than in a 
low NK cell-percentage population (Fig. 38) (Zhang et al., 2006).   
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                         Culture days 
FIG. 38 γδ T cells proliferate faster in a high NK cell-percentage population.  Adapted from Zhang et al., 
2006 
This finding suggests that NK cell numbers affect the proliferation response of γδ T cells 
and that in the event of NK cell depletion, γδ T cell proliferation would decrease (Zhang 
et al., 2006). 
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THE ADAPTIVE IMMUNE RESPONSE AGAINST MYCOBACTERIUM 
TUBERCULOSIS 
Inter leukin 17 (IL-17)  
 IL-17 is a potent inflammatory cytokine secreted by T lymphocytes such as Th17 
and CD4+ 
IL-17-Producing Cells 
T cells (as reviewed by Peng et al., 2008).  IL-17 induces chemokine 
production and augments neutrophil accumulation (as reviewed by Lockhart et al., 2006).  
The production of IL-17 by Th17 cells is regulated by IFN-γ.  It is hypothesized that IFN-
γ and IL-17 have the ability to counterregulate each other during chronic mycobacterial 
infections (Cruz et al., 2006).  
In a study to investigate the source of IL-17 in tuberculosis patients, the 
proportion of IL-17-producing cells in their peripheral blood was measured.  γδ T cells 
were the main source of IL-17, with other IL-17-producing cells making up a small 
proportion of the peripheral blood lymphocytes.  The overall percentage of IL-17-
producing cells in the peripheral blood of the tuberculosis patients and healthy donors 
was very similar (Fig. 39b), however the percentage of IL-17-producing γδ T cells was 
significantly higher in tuberculosis patients (Fig. 39c) (Peng et al., 2008).   
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FIG. 39 The percentage of IL-17- producing γδ T cells is significantly higher in tuberculosis patients.   (B) 
The percentages for IL-17+ cells of lymphocytes.  (C) The percentages for CD3+ cells and γδ T cells among 
IL-17+
 
 cells.  Adapted from Peng et al., 2008 
Purified cells from the lungs of Mycobacterium tuberculosis-infected mice at 2, 4, and 52 
weeks postinfection were studied.  The purified cells were fractioned into three groups.  
Group 1 consisted of CD4+ and CD8+ 
 
T cells, B cells, and macrophages (“CD4 pool”).  
Group 2 was composed of γδ T cells.  Group 3 consisted of NK cells, NK T cells, and 
other cell types (“flow through”).  Each cell group was stimulated with supernatant from 
Mycobacterium tuberculosis-infected dendritic cells for 48h and tested for IL-17 
production using ELISPOT.  The results showed that the γδ T cells and “flow through” 
fractions were capable of producing IL-17 at all three time points at a higher level than 
the “CD4 pool” (Fig. 40) (Lockhart et al., 2006).   
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FIG. 40 γδ and other non-CD4 T cells contribute to IL-17 production in Mycobacterium tuberculosis-
infected mice.  (B) Lungs at 2 weeks postinfection, (C) Lungs at 4 weeks postinfection, (D) Lungs at 52 
weeks postinfection.  Adapted from Lockhart et al., 2006 
 
The results obtained from this particular experiment show that γδ T cells and other non-
CD4+ or CD8+ T cells are capable of producing IL-17 during Mycobacterium 
tuberculosis infection and that γδ T cells produce more IL-17 than CD4+
Counterregulation of IL-17 and IFN-γ 
 T cells 
(Lockhart et al., 2006). 
 IFN-γ regulates IL-17 production both in vitro and in vivo (as reviewed by Cruz et 
al., 2006).  In an experiment using C57BL/6 and IFN-γ-deficient mice, IFN-γ production 
was tested to see if it could limit IL-17 T cell responses to BCG.  The C57BL/6 and IFN-
γ-deficient mice were intravenously infected with BCG and the expansion of IL-17-
producing CD4+
 
 T cells was observed.  The IFN-γ-deficient mice produced more IL-17 
than the C57BL/6 mice at both 15 and 21 days postinfection (Fig. 41).  This finding 
supports the hypothesis that IFN-γ regulates the IL-17 response (Cruz et al., 2006). 
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FIG. 41 IFN-γ-deficient mice produce more IL-17 than wild-type C57BL/6 mice following BCG infection. 
C57BL/6 mice (shaded bar).  IFN-γ-deficient mice (striped bar).  Adapted from Cruz et al., 2006 
 
 In an experiment conducted by Peng et al. (2008) the percentage of IFN-γ-producing γδ 
T cells in the peripheral blood of tuberculosis patients was significantly lower than 
healthy donors while the percentage of IL-17-producing γδ T cells was significantly 
higher in the tuberculosis patients (Fig. 42b).  Further testing showed the ratio of IFN-γ-
producing γδ T cells to IL-17-producing γδ T cells in the peripheral blood of tuberculosis 
patients to be significantly lower than those of the healthy donors (Fig. 42c).  This 
finding confirms that IL-17-producing γδ T cells are increased in tuberculosis patients 
(Peng et al., 2008). 
 
FIG. 42 IL-17-producing γδ T cells are increased in the peripheral blood of tuberculosis patients.   
Adapted from Peng et al., 2008 
 
 The findings from these experiments support the hypothesis that an inability of 
tuberculosis patients to produce enough IFN-γ to dampen IL-17-mediated inflammation 
during chronic Mycobacterium tuberculosis infection predisposes them to inappropriate 
tissue-damaging responses (Cruz et al., 2006). 
CD4+ and CD8+
 The protective immune response against Mycobacterium tuberculosis relies on 
cell mediated immunity.  Mycobacterium tuberculosis is a pathogen that primarily resides 
within cells, usually macrophages.  Because of the survival method used by 
 T Cells 
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Mycobacterium tuberculosis, T cell effector mechanisms rather than antibodies are 
required to control and/or eliminate the bacteria (Flynn et al., 2001).  It is the interaction 
between infected macrophages and T cells that defines the successful elimination of 
Mycobacterium tuberculosis from an infected individual (van Crevel et al., 2002).  A 
proper protective immune response mounted against Mycobacterium tuberculosis occurs 
in a series of steps.  First, the bacteria are delivered by resident and/or recruited APCs to 
secondary lymphoid tissues.  Second, the APCs migrate to regions of the secondary 
lymphoid tissues that are enriched in naïve CD4+ and CD8+ T cells that become activated.  
Third, the activated CD4+ and CD8+ T cells migrate via the bloodstream to the site/s of 
infection. Lastly, the CD4+ and CD8+
CD8
 T cells emigrate from the intravascular space into 
the tissue where they either deliver macrophage-activating cytokines or kill the infected 
cells by direct contact (Peters et al., 2003).   
+
 At one time research focused primarily on CD4
 T Cell Response to Mycobacterium tuberculosis Infection  
+ T cell responses to 
Mycobacterium tuberculosis infection.  Studies have shown CD4+ T cells to be two-fold 
more abundant than CD8+ T cells at sites of tuberculosis infection in both mice and 
humans (as reviewed by Peters et al., 2003).  Recently, more interest has been placed into 
the role that CD8+ T cells have in mounting an immune response against Mycobacterium 
tuberculosis infection.  Serbina et al. (2001) reported that the percentage of CD8+ T cells 
in Mycobacterium tuberculosis-infected lungs of CD4+ T cell-deficient mice was two-
fold higher than in the lungs of wild-type mice following aerosol infection (Fig. 44).  
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FIG. 43 CD4+ T cell-deficient mice have more CD8+ T cells in their lungs than wild-type mice following 
Mycobacterium tuberculosis infection.  Wild-type mice(open square).   CD4+
 
 T cell-deficient mice (closed 
square).  Adapted from Serbina et al., 2001 
Direct lysis and IFN-γ production are two effector functions used by CD8+ T cells (Flynn 
et al., 2001) and CD4+ T cells are important for the maintenance of CD8+ T cell effector 
functions (Serbina et al., 2001).  So despite the increase in the number of CD8+ T cells, 
further investigation revealed significant reductions in the specific lysis mediated by the 
cytotoxic CD8+ T cells in the lungs of CD4+
FIG. 44 Lysis mediated by cytotoxic CD8
 T cell-deficient mice (Fig. 45) 
 
+ T cells is reduced in the lungs of CD4+ T cell-deficient mice. 
Wild-type mice (squares).  CD4+ T cell-deficient mice  
 
(circles).  Adapted from Serbina et al., 2001 
(Serbina et al., 2001). The results from the two experiments conducted by Serbina et al. 
(2001) suggest that the cytotoxic activity of Mycobacterium tuberculosis-specific 
cytotoxic CD8+ T cells is compromised in the absence of CD4+ T cells.   
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Based on the newfound information pertaining to the role that CD8+ T cells have 
in combating Mycobacterium tuberculosis infection in the mouse model, Carranza et al. 
(2006) analyzed the role of this specific T cell subset in individuals harboring active 
Mycobacterium tuberculosis disease.  To test if exposure to Mycobacterium tuberculosis 
aerosol induced bactericidal activity mediated by T cells, autologous blood CD8+ and 
CD4+ T cells from healthy individuals were added to attenuated H37Ra and virulent 
H37Rv Mycobacterium tuberculosis-infected alveolar macrophages.  The H37Ra and 
H37Rv Mycobacterium tuberculosis-infected cultures both controlled the growth of the 
tubercle bacilli when the alveolar macrophages were cocultured with CD8+
 
 T cells (Fig. 
46) (Carranza et al., 2006).  
FIG. 45 Both H37Ra- and H37Rv-infected alveolar macrophage cultures control the growth of tubercle 
bacilli when cocultured with CD8+
 
 T cells.  Alveolar macrophages alone (closed circles).  Alveolar 
macrophage/ CD8 coculture (open circles).  Adapted from Carranza et al., 2006 
This finding further supports the participation of CD8+
 
 T cells in the immune response 
against Mycobacterium tuberculosis infection. 
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IFN-γ Production by CD8+
 To test the influence that CD8
 T Cells 
+ T cells had on the production of IFN-γ, alveolar 
macrophage cultures and alveolar macrophage/CD8+ T cell cocultures of healthy 
individuals were infected with the H37Ra or H37Rv Mycobacterium tuberculosis strains 
for one week.  Both strains caused an increase in IFN-γ concentration from day 0 to day 
7.  The H37Rv-infected alveolar macrophage cultures and alveolar macrophage/CD8+ T 
cell cocultures displayed IFN-γ concentrations that were two-three times higher than the 
H37Ra strain.  However, IFN-γ concentrations of the alveolar macrophage/CD8+
 
 T cell 
cocultures were one- to four times higher than the alveolar macrophage cultures of both 
strains (Fig. 47) (Carranza et al., 2006). 
FIG. 46 IFN-γ production in alveolar macrophage/CD8+ 
 
T cell cocultures is significantly higher than 
alveolar macrophage cultures alone.   Alveolar macrophages alone (black bars).  Alveolar macrophage/CD8 
coculture (white bars).  Adapted from Carranza et al., 2006 
The results show that CD8+ T cells are capable of inhibiting Mycobacterium tuberculosis 
growth and producing IFN-γ, two elements necessary in combating tuberculosis.  To 
compare the amount of IFN-γ produced by CD8+ T cells to that produced by CD4+ T 
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cells, the same experiment was performed except that alveolar macrophage/CD4+ T cell 
cocultures were used in place of alveolar macrophage/CD8+ T cell cocultures.  Similar to 
the results given when studying CD8+ T cells, the IFN-γ concentrations were higher in 
the alveolar macrophage/CD4+
 
 T cell cocultures than in the alveolar macrophage cultures 
alone (Fig. 48) (Carranza et al., 2006). 
FIG. 47 IFN-γ concentrations are higher in alveolar macrophage/CD4+
 
 T cell cocultures than alveolar 
macrophages alone.  Alveolar macrophages alone (black circles).  Alveolar macrophage/ CD4 coculture 
(white circles). IFN-γ production in alveolar macrophages alone (black bars).  IFN-γ production in alveolar 
macrophages/CD4 coculture (gray bars). Adapted from Carranza et al., 2006 
Overall, it was shown that IFN-γ levels of the alveolar macrophage/CD4+ T cell 
cocultures were higher than those of the alveolar macrophage/CD8+ T cell cocultures 
regardless of the Mycobacterium tuberculosis strain used.  The findings from these two 
experiments suggest that Mycobacterium tuberculosis antigen-specific human CD4+ T 
cells are the primary source of IFN-γ and that CD8+ T cells although less than CD4+
IFN-γ Production by CD4
 T 
cells, do contribute to IFN-γ production in the event of Mycobacterium tuberculosis 
infection (Carranza et al., 2006). 
+
 To take a closer look at the role of CD4
 T Cells 
+ T cells in Mycobacterium tuberculosis, 
Caruso et al. (1999) performed a study involving wild-type, MHC II-deficient, and CD4+ 
T cell-deficient mice.  The results from their experiment showed all three groups of mice 
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producing low levels of IFN-γ one week postinfection while at two weeks postinfection 
IFN-γ production in the MHC II-deficient and CD4+ T cell-deficient mice was only 44% 
of that in the wild-type mice.  It was not until four weeks postinfection that the total 
amount of IFN-γ within the lungs of the wild-type and CD4+
 
 T cell-deficient mice was 
similar (Fig. 49) (Caruso et al., 1999). 
FIG. 48 IFN-γ production in lung cells from Mycobacterium tuberculosis-infected mice.  Wild-type mice 
(open square).  MHC II-deficient mice (closed circle).  CD4+
 
 T cell-deficient mice (closed triangle).  
Adapted from Caruso et al., 1999 
Further analysis uncovered that IFN-γ production by CD8+ T cells in the CD4+ T cell-
deficient and wild-type mice was the same at two weeks postinfection but that the 
contribution of CD4+ T cells to IFN-γ production was absent in the MHC II-deficient and 
CD4+ T cell-deficient mice (Caruso et al., 1999).  It is hypothesized that the absence of 
CD4+ T cells in MHC II-deficient and CD4+ T cell-deficient mice may be responsible for 
preventing CD8+ T cells from becoming cytotoxic, an occurrence that may contribute to 
MHC II-deficient and CD4+ T cell-deficient mice being more susceptible to 
Mycobacterium tuberculosis infection.  The findings from this experiment suggest that 
IFN-γ production by CD4+ T cells is needed to have an effective immune response early 
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in Mycobacterium tuberculosis infection and that IFN-γ production by CD8+ T cells is 
insufficient to control infection on its own (Caruso et al., 1999). 
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DRUG TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS 
 As more knowledge and understanding about how Mycobacterium tuberculosis is 
recognized and controlled by the immune system surfaces, the development of effective 
vaccines remains an important goal in controlling tuberculosis infection.  Vaccination is 
still the best hope for ultimately eradicating this disease (Schluger, 2001), however, there 
are challenges in attempts to design and develop successful vaccines to fight against 
Mycobacterium tuberculosis infection.  The pathogenesis of tuberculosis infection is 
studied in animal models and there is no completely satisfactory animal model of human 
tuberculosis available (Schluger, 2001).  This presents a challenge because animal 
models permit the study of the risk of actual tuberculosis infection whereas human 
studies focus on the progression of tuberculosis infection to active disease in patients 
harboring latent infection (Schluger, 2001). 
Although there is no perfect animal model for the study of Mycobacterium 
tuberculosis in humans, animal studies have the potential to provide useful information 
about Mycobacterium tuberculosis infection.  Various animal hosts (Table 3) have been 
used for tuberculosis studies but the expense of some of the animals and the cost of 
keeping them under level III biosafety conditions has made the mouse the model of 
choice (Orme, 2005).  
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TABLE 3 Overview of animal models for vaccine testing.  Adapted from Orme, 2005 
Vaccine testing in the mouse model occurs in a series of steps.  First the mice are 
vaccinated against Mycobacterium tuberculosis then infected with virulent 
Mycobacterium tuberculosis a few weeks later.  Following infection with Mycobacterium 
tuberculosis the mice are screened at various time points and at 30 days postinfection are 
tested for the bacterial load in their lungs and other organs such as the spleen and liver.  
The bacterial loads of the infected mice are then compared to those of the uninfected 
control mice (Orme, 2005).  The results produced in these studies allow for identification 
and evaluation of vaccine longevity and effectiveness as well as the degree to which the 
mice are able to generate both a TH1-type CD4+ and CD8+
Vaccines 
 T cell response (Orme, 2005).  
In designing an effective vaccine against Mycobacterium tuberculosis infection it 
is important for the vaccine to possess certain qualities.  An effective vaccine should be 
able to induce a good immune response.  The vaccine should consist of molecules that are 
foreign to the host and complex, demonstrating stability and degradability so that the 
antigenic material gets processed and presented to lymphocytes (Sable et al., 2007).  In 
searching for good vaccine candidates it is ideal for the vaccine to be safe and 
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inexpensive, provide full protection after a single administration, provide worldwide 
protection against disease and infection, induce lifelong immunological memory, and not 
compromise the tuberculin skin tests (TSTs) (Andersen, 2001). 
Recombinant Bacillus Calmette-Guerin (BCG)  
The recombinant Bacillus Calmette-Guerin (BCG) vaccine, originally developed 
from Mycobacterium bovis, was designed nearly a century ago.  BCG is considered to be 
a safe cost effective option for vaccinating against Mycobacterium tuberculosis infection 
(Orme, 2005).  However, multiple BCG vaccine trials carried out in different countries 
have shown this vaccine to be variable in its degree of protection against Mycobacterium 
tuberculosis infection.  BCG possesses an effectiveness ranging from 0-80% and its 
efficacy is believed to wane with time, remaining protective for only 10-20 years (as 
reviewed by Sable et al., 2007).  Studies have shown that tuberculin reactivity following 
BCG vaccination depends on the age of administration.  Administration of the BCG 
vaccine during infancy has been shown to be highly effective in protecting against severe 
cases of Mycobacterium tuberculosis due to the rapid waning of tuberculin reactions (as 
reviewed by Menzies, 2000).  BCG vaccination of individuals after the first year of life, 
however, has been shown to result in persistent tuberculin reactions (as reviewed by 
Menzies, 2000).  It is argued that this loss of protection from childhood through young 
adult life may be the reason for the increased incidence of tuberculosis infection (Sable et 
al., 2007).  Several reasons have been suggested for variation in the protective efficacy an 
overall failure of the BCG vaccine.   Variations in the effectiveness of the BCG vaccine 
are believed to be either directly or indirectly related to genetic differences in vaccinated 
populations, differences in BCG strains, dose and vaccination protocols, over-attenuated 
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parent strains, administration of the vaccine to already sensitized or infected individuals, 
and the interaction between BCG and environmental mycobacteria which can mask or 
block its protective effect (as reviewed by Sable et al., 2007). 
 The 0-80% variable efficacy of BCG and the difficulty of improving its protection 
have lead to the need for more effective tuberculosis vaccines (as reviewed by Sable et 
al., 2007).    The United States and other industrialized countries with low incidences of 
tuberculosis infection have discontinued the use of the BCG vaccine.  BCG vaccination 
has been shown to affect tuberculin skin tests (TSTs) which makes it difficult to interpret 
the results (Cohn, 2001).  Because there is no reliable method to distinguish between an 
individual displaying a true-positive TST because of actual Mycobacterium tuberculosis 
infection from an individual with a false-positive TST resulting from prior vaccination 
with BCG, creating a more effective vaccine to aid in the prevention of  Mycobacterium 
tuberculosis is one of extreme importance (Cohn, 2001).   
Culture Filtrate Protein (CFP) 
 In early attempts to develop effective vaccines against Mycobacterium 
tuberculosis infection, heat-killed bacilli were the preparations of choice.  However, 
vaccines containing heat-killed tubercle bacilli only gave rise to non-specific 
inflammatory responses as opposed to the long-term protection that was desired (Orme, 
1988).  Only mice that were immunized with live Mycobacterium tuberculosis generated 
a protective T cell response over a 30 day experimental period (Orme, 1988).  It is 
hypothesized that the secreted proteins of Mycobacterium tuberculosis present in the 
secretory or total culture filtrate protein (CFP) pools are the key protective antigens of the 
tubercle bacillus responsible for the rise of the T cell-mediated host immune responses 
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necessary for the control and containment of Mycobacterium tuberculosis infection 
(Roberts et al., 1995).  Today, the use of CFP vaccines is being explored because of their 
ability to impart significant protection against tuberculosis infection in the mouse model.  
Mice immunized with purified CFP antigens from the Mycobacterium tuberculosis 
Erdman strain and challenged with a low-dose aerosol of Mycobacterium tuberculosis 
were resistant to tuberculosis infection.  Immunization with the CFP antigens generated 
CD4+
Early Secretory Antigenic Target of 6 kDa (ESAT-6) 
 T cells that secreted IFN-γ (Roberts et al., 1995), presenting the possibility for the 
use CFP vaccines.  However, despite findings from CFP experiments, there are two 
limitations preventing CFP from being an effective vaccine.  The first limitation is that 
CFP provides initial protection upon infection with Mycobacterium tuberculosis, but like 
BCG, the effectiveness wanes with time.  The second limitation of using CFP as vaccine 
is that it has to be delivered in adjuvant (Roberts et al., 1995).  Another setback for the 
use of CFP vaccines reside in the differences that arise with each culture condition and 
the risk of the vaccine possibly possessing both protective and deleterious molecules 
because of improper purification (Sable et al., 2007). 
 Live vaccines can cause life-threatening disease in immunocompromised 
individuals, a fact that has lead to the development of subunit vaccines.  Mycobacterial 
components such as proteins, lipids, and carbohydrates are screened from both secretory 
and subcellular compartments to develop subunit vaccines (Sable et al., 2007).  The early 
secretory antigenic target of 6 kDa (ESAT-6), a secreted antigen of Mycobacterium 
tuberculosis, has been shown to give a strong protective response against tuberculosis 
infection (Orme, 2005).  Low molecular weight polypeptides such as ESAT-6 make ideal 
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vaccine candidates because of their ability to induce dominant TH1 responses with 
negligible TH2 responses (Sable et al., 2007).  In mouse macrophages ESAT-6 
demonstrated the ability to enhance IFN-γ-induced accumulation of iNOS, suggesting its 
participation in NO. release via macrophage stimulation (Singh et al., 2005).  The strong 
antigenicity of ESAT-6 is hypothesized to result from its small size, possibly rendering it 
more susceptible to presentation to and processing by CD4+ T lymphocytes following its 
release in the phagosome.  It is also hypothesized that ESAT-6 gains access to the 
cytoplasm and class-I processing machinery contained in the proteosome, leading to 
strong cytotoxic T cell responses (as reviewed by Sable et al., 2007).  As with other 
vaccines however, vaccination with ESAT-6 has presented a problem.  The problem is 
that ESAT-6 has a low inherent immunogenicity and requires being complexed with 
multiple strong adjuvants to mount a sufficient immune response.  Mice immunized with 
ESAT-6 complexed with the hydrophobic adjuvant monophosphoryl lipid A (MPL) did 
not give rise to IFN-γ-producing T cells and mice immunized with ESAT-6 complexed 
with dimethyl dioctadecylammonium bromide (DDA) give rise to a low number IFN-γ-
producing T cells.  It was not until ESAT-6 was emulsified in DDA-MPL that a very high 
number of IFN-γ-secreting CD4+
Inhalable Microparticles 
 T cells was observed (Brandt et al., 2000).  The results 
from this experiment emphasizes how the use and choice of adjuvant influences the 
efficacy of ESAT-6 in mounting a sufficient IFN-γ-producing T cell response.   
 The manner in which drugs are delivered to targeted alveolar macrophages can 
affect their activation (Sharma et al., 2007).  Sharma et al. (2001) showed that drug 
concentrations found in the serum or macrophages of mice can vary based on the route of 
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administration.  They observed that high serum drug concentrations did not necessarily 
lead to high intracellular drug concentrations and that high intracellular drug 
concentrations achieved by administering microparticles did not necessarily lead to high 
serum drug concentrations (Fig. 50) (Sharma et al., 2001).   
 
FIG. 49 The route of drug administration can affect the activation of alveolar macrophages in mice.  
Adapted from Sharma et al., 2001 
 
A proposed reason for treatment failure in the event of Mycobacterium tuberculosis 
infection is that drug concentrations achieved in the cytosol of targeted cells through oral 
administration are not sufficient enough to kill the bacteria residing within the 
macrophages (Sharma et al., 2001).   
 Macrophages infected with Mycobacterium tuberculosis retain their ability to 
phagocytose and process additional material (Oh et al., 1996 as reviewed by Sharma et 
al., 2007).  Because the role of alveolar macrophages is to uptake bacteria found in the 
lungs and transport it to secondary lymphoid organs, it is possible that the bacteria could 
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be exposed to, taken up by the bloodstream, and delivered to sites of macrophage 
trafficking.  Sharma et al. (2001) proposed that loading resident alveolar macrophages of 
the lung with biodegradable drug-containing microparticles ranging in size from 0.5-3 
microns would lead to transport of the drug to sites where alveolar macrophages migrate, 
thus preventing the spread of Mycobacterium tuberculosis which would otherwise go 
undetected.  Inhaled microparticles phagocytosed by alveolar macrophages may deliver 
larger amounts of drug to the cytosol than using the oral route or by dissolving the drugs 
in body fluids (Sharma et al., 2001).  Goals of using inhalable microparticles as opposed 
to oral drug administration to battle Mycobacterium tuberculosis infection include 
reducing the drug dose, reducing the dose frequency and toxicity, improving patient 
compliance, and most importantly targeting specific macrophages that harbor 
Mycobacterium tuberculosis (Sharma et al., 2001).  The overall objective of using 
inhalant microparticles to treat tuberculosis infection is to achieve high intracellular drug 
concentrations in the infected macrophages (Sharma et al., 2007).   
Isoniazid (H) and Rifampicin (R) 
In developing an effective aerosol drug to treat Mycobacterium tuberculosis 
infection, it is important for the drug to be potent and long-lived.  In an attempt to prevent 
drug resistance while treating Mycobacterium tuberculosis, single-drug therapy aerosols 
are not used (as reviewed by Sharma et al., 2001) and inhalable microparticles containing 
multiple drugs in a dry powder are preferred (Sharma et al., 2001).  In treating 
Mycobacterium tuberculosis infection Isoniazid (H) and Rifampicin (R) are the two first-
line anti-tuberculosis inhalant drugs of choice (Sharma et al., 2001).  To test the potency 
of H and R, mouse macrophages were exposed to equivalent amounts of H and R in a 
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time spanning from 0 to 30 minutes.  The macrophages were exposed to H and R 
dissolved in culture medium and in microparticle form.  Both H and R maintained higher 
concentrations within the macrophages after 30 minutes in microparticle form as opposed 
to the soluble form that presented a lower concentration within the macrophages (Fig. 51) 
(Sharma et al., 2001).  
 
FIG. 50 Both H and R maintain higher concentrations within alveolar macrophages in microparticle form.  
Adapted from Sharma et al., 2001 
 
 In a three day study of mice infected with Mycobacterium tuberculosis, administration of 
H and R aerosol resulted in the microparticles targeting alveolar macrophages of both the 
Mycobacterium tuberculosis-infected mice and the uninfected control mice.  Following 
the administration of H and R, the macrophages of the mice were up to 50µm in diameter 
and contained 10 or more particles.  The alveolar macrophages also displayed no signs of 
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intact mycobacteria, a finding that presents promise for the use of aerosols to treat 
Mycobacterium tuberculosis infection (Fig. 52) (Sharma et al., 2007). 
 
FIG. 51 Alveolar macrophages display no signs of intact mycobacteria following the administration H and 
R aerosol.  The arrow indicates electron-opaque debris.  Adapted from Sharma et al., 2007 
 
Effect of H and R on NO.
Intracellular RNIs are direct in their anti-mycobacterial function (Sharma et al., 
2007).  An increase in NO
 Production 
. production indicates that alveolar macrophages have become 
activated. Sharma et al. (2007) exposed uninfected alveolar macrophages and 
Mycobacterium tuberculosis-infected alveolar macrophages to H and R drug containing 
microparticles over a set period of 3, 9, and 24h.  The results showed larger amounts of 
NO. being produced 9h after infection with Mycobacterium tuberculosis when compared 
to the untreated control.   When equivalent amounts of H and R were used in solution, no 
significant increases in NO. production were observed (Fig. 53) (Sharma et al., 2007).  
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FIG. 52 H and R activate alveolar macrophages better in microparticle form than in solution at 3 (filled 
bars), 9 (hatched bars) and 24 (white bars) h after treatment. ‘U+MP’ refers to uninfected cells treated with 
microparticles, ‘Inf’ refers to cells receiving 25 moi of M. tuberculosis but no further treatment, ‘Inf+ D’ 
refers to infected cells exposed to drugs in solution and ‘Inf+ MP’ refers to infected cells treated with an 
equivalent dose of microparticles..  Adapted from Sharma et al., 2007 
 
These findings support the observation that inhaled microparticles have a greater effect 
on alveolar macrophage activation than drugs in solution.     
Effect H and R on Cytokine Production 
 To understand the effect that drug treatment has on Mycobacterium tuberculosis 
infection, a three day experiment comparing TNF-α, IFN-γ, IL-10, and IL-12 cytokine 
production by cells recovered from different mouse subjects was conducted.  The results 
showed an up-regulation of all four cytokines in untreated Mycobacterium tuberculosis-
infected mice; however, there was no significant increase in IL-12 production.  Oral drug 
treatment with H and R down-regulated the production of all four cytokines while the 
combination of oral and inhalant drug administration had no significant effect on any of 
the cytokines.   Inhalation drug treatment alone induced significant TNF-α production 
and downregulated IFN-γ production (Fig. 54) (Sharma et al., 2007).  
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FIG. 53 Comparison of cytokine production by cells recovered from mice at 3 days postinfection.  
Uninfected, untreated mice (XX); mice infected with M. tuberculosis H37Ra and left untreated (IX); or 
infected and treated for 3 days with oral doses (IO), a combination of oral and inhalation dosing (IOI) or 
inhalations alone (II).  Adapted from Sharma et al., 2007 
 
 Of the four cytokines tested, TNF-α and IL-12 were the most significantly induced 
following treatment with H and R microparticles (Fig. 55) (Sharma et al., 2007).   
 
FIG. 54 TNF-α and IL-12 are induced the most following treatment with H and R microparticles.  Neither 
infection nor treatment (filled bars), infection alone (rising hatching), or infection with M. tuberculosis 
followed by treatment with drugs in solution (cross-hatching), drug-containing microparticles (white bars) 
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or blank, drug-free microparticles (falling hatching). Uninfected cells administered drug-containing 
microparticles (vertical lines) served as an additional control.  Adapted from Sharma et al., 2007 
 
These findings continue to support the important roles that TNF-α and IL-12 have in 
fighting Mycobacterium tuberculosis infection.  
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DISCUSSION 
Mycobacterium tuberculosis is a devastating disease that strategically evades 
destruction by the host immune response.  The innate and adaptive immune responses 
triggered by this mycobacterium create a cascade of events that work to limit and contain 
the growth of infection.  The host defense mechanisms mounted against Mycobacterium 
tuberculosis provides a glance into how the body naturally attempts to fight this disease 
and are summarized in Table 4 and Figure 55.    
Macrophage apoptosis is hypothesized to contribute to the host innate immune 
response by containing and limiting the growth of tubercle bacilli.  The study conducted 
by Kelly et al. (2008) addressed the possibility of bystander apoptosis where uninfected 
bystander cells undergo apoptosis as a way to prevent the dissemination of infection.  It 
was concluded that bystander apoptosis was not due to the release of soluble factors by 
apoptotic Mycobacterium tuberculosis-infected macrophages but rather the result of cell-
cell contact between the infected apoptotic cells and the uninfected bystander cells.  Cell-
cell contact between the infected and uninfected cells may have been required for 
apoptosis to occur, but Kelly et al. (2008) failed to investigate the mechanism responsible 
for the cell-cell contact-induced apoptosis of the uninfected bystander cells.  It would 
have benefited them to take the experiment a step further to investigate the reason for this 
occurrence by considering the participation of gap junctions or the interaction of cell 
surface molecules with one another.  Because no further experimentation was conducted 
to explain the mechanism behind the cell-cell contact-induced apoptosis, their findings 
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have to be interpreted with great caution and perhaps a follow-up study designed to 
address how cell-cell contact-induced apoptosis occurred should be conducted.  
Nitric oxide (NO.
iNOS gene-disrupted mice (NOS2
) is one of the few bactericidal agents produced by infected 
macrophages that is capable of killing Mycobacterium tuberculosis.  Miller et al. (2004) 
showed that iNOS is recruited to phagsomes not containing mycobacteria and Davis et al. 
(2007) showed that iNOS is only recruited to phagosomes containing dead mycobacteria.  
The combined findings from both experiments show that live mycobacteria have a way of 
disrupting the recruitment of iNOS to infected phagosomes and it encourages the 
progression of Mycobacterium tuberculosis infection.  Further experimentation by Miller 
et al. (2004) and Davis et al. (2007) showed that alterations or deletions in one or more of 
the elements contributing to the action of the actin cytoskeleton can interfere with 
microfilament motility and disrupt the recruitment of iNOS to phagosomes. 
-/-)  displayed a higher bacterial burden in their 
lungs following  Mycobacterium tuberculosis infection, however they were able to mount 
an adaptive immune response comparable to that of wild-type mice (Beisiegel et al., 
2009).  The fact that NOS2-/- mice had an infiltration of IFN-γ- and TNF-α-producing 
CD4+ and CD8+ T cells similar to  that of wild-type mice but still succumbed to infection 
strongly supports the notion that NO. production is vital for fighting Mycobacterium 
tuberculosis infection.  The results from their experiment also suggest that 
proinflammatory cytokines alone are not enough to fight Mycobacterium tuberculosis 
infection in NOS2-/-
The hypothesis that human alveolar macrophages are capable of producing NO
 mice. 
. in 
the event of Mycobacterium tuberculosis infection was confirmed in a studies by Rich et 
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al. (1997) and Wang et al. (1998).  Rich et al. (1997) showed that supernatant from 
human Mycobacterium tuberculosis-infected alveolar macrophages contained NO. that 
could be inhibited through the use of a iNOS inhibitor.  Wang et al. (1998) conducted a 
clinical study that fell in line with the results given by Rich et al. (1997).  Wang et al. 
(1998) showed that patients with active Mycobacterium tuberculosis infection had 
significantly higher levels of NO. exhaled in their breath than healthy control subjects.  
Further experimentation revealed that iNOS expression by the alveolar macrophages of 
the tuberculosis patients was significantly higher than the control subjects and that the 
increase in iNOS expression correlated with the level of exhaled NO..  The findings from 
this clinical study have the potential to be used as a screening tool for people suspected of 
harboring Mycobacterium tuberculosis infection.  Since the level NO. exhaled in the 
breath of the tuberculosis patients correlated with the amount of NO.
TLR2 and TLR4 have displayed their importance in limiting and controlling the 
advancement of Mycobacterium tuberculosis.  In the absence of TLR2 and/or TLR4, 
infection with Mycobacterium tuberculosis was shown to be fatal in mutant mice.  
Following infection with Mycobacterium tuberculosis, TLR2- and TLR4-deficient mice 
displayed bacterial burdens in their lungs that were significantly higher than the bacterial 
burdens present in the wild-type control mice.   The mice were ultimately shown to have 
a large decrease in IL-12 production (Reiling et al., 2002) which is hypothesized to be 
responsible for their increased susceptibility to infection with Mycobacterium 
tuberculosis.  This finding is of great importance because IL-12 is a proinflammatory 
 being produced,  
perhaps breathalyzer screenings could be used to determine the existence of a 
mycobacterial infection and its seriousness. 
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cytokine produced upon TLR activation and in essence bridges the innate and adaptive 
immune responses through CD4+
γδ T cells contribute to the proinflammatory responses triggered upon infection 
with Mycobacterium tuberculosis.  In a study conducted by Li et al. (1998) patients with 
active tuberculosis infection were shown to have a significantly reduced number of 
Mycobacterium tuberculosis-reactive γδ T cells in their blood and bronchoalveolar lavage 
(BAL) both before and after receiving drug chemotherapy.  The decrease in the number 
of Mycobacterium tuberculosis-reactive γδ T cells was attributed to the progression and 
severity of infection in the patients.  The problem with this conclusion is that the type of 
drug treatment chosen to treat the Mycobacterium tuberculosis infection is one that is 
non-specific and kills infected cells as well as healthy cells.  Active disease patients and 
patients with latent disease were administered chemotherapy for a time span of 2 to 16 
months.  At the 2 month mark only the active disease patients’ γδ T cell numbers were 
counted.  Beyond 2 months, both the active and latent disease patients’ γδ T cell numbers 
were counted.    This presents a problem because the counting of the γδ T cells for the 2 
patient groups was not consistent throughout the experiment.  Since the γδ T cell numbers 
of patients with latent Mycobacterium tuberculosis was not measured 2 months after drug 
chemotherapy, how can it be concluded that they regained their γδ T cell numbers after 
16 months of treatment?  I understand that healthy individuals cannot be administered 
chemotherapy treatments for experimental purposes; however, Li et al. (1998) concluded 
 T cell recruitment and NK cell activation.  Without 
adequate IL-12 production, receiving aid from other innate immune components such as 
γδ T cells or the proinflammatory cytokines IFN-γ and TNF-α is inhibited and results in 
uncontrollable growth of tubercle bacilli. 
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that the γδ T cell numbers of the active tuberculosis patients was significantly decreased 
despite the experimental length.  Without the use of a healthy control to undergo the same 
treatment regimen to see exactly how their γδ T cell numbers are affected following drug 
chemotherapy, how can it be concluded that the decrease seen in the γδ T cell numbers of 
the tuberculosis patients is really as significant as the experiment claims?  Perhaps to 
address this question future studies should be performed using mice so that the extent of 
the effect that drug chemotherapy places on γδ T cell numbers in healthy subjects, active, 
and latent Mycobacterium tuberculosis-infected subjects can be observed.  
Lockhart et al. (2006) conducted a study to show that γδ T cells and other non-
CD4+ or CD8+ T cells are capable of producing IL-17 during Mycobacterium 
tuberculosis infection.  The findings from their study show that γδ T cells produce more 
IL-17 than CD4+ T cells however, the way that they present their conclusion is 
misleading.  Purified cells from Mycobacterium tuberculosis-infected mice were 
fractioned into three groups but the group referred to as the “CD4 pool” consisted of 
more than CD4+ T cells.  The “CD4 pool” also included CD8+ T cells and B cells.  The 
results from their experiment are misleading because if it is concluded that other non-
CD4+ cells are capable of producing IL-17, then it only makes sense to have a group only 
consisting of CD4+
Peng et al. (2008) showed that the percentage of IFN-γ-producing γδ T cells was 
lower than the percentage of IL-17-producing γδ T cells in tuberculosis patients.  It is 
hypothesized that IFN-γ regulates the IL-17 response and that IL-17 can in return regulate 
 cells to serve a control.  It would have possibly been more accurate to 
refer to the “CD4 pool” as the “adaptive immune cell pool” considering that all of the 
cells in the group are involved in adaptive immunity. 
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the IFN-γ response.  The results from their study suggest that the inability of tuberculosis 
patients to produce enough IFN-γ to dampen IL-17-mediated inflammation during 
Mycobacterium tuberculosis infection predisposes them to inappropriate tissue-damaging 
responses.  I on the other hand interpret their results a little differently.   The way that I 
interpret their findings is that if IL-17 is placing a damper on the IFN-γ responses, then 
macrophage activation, CD8+ T cell recruitment, and most importantly NO. 
 The development of more effective drugs and the search for better treatment 
options for eradicating Mycobacterium tuberculosis remains ongoing.  Despite the 
development of different vaccine options, each one presents its own set of problems.  For 
instance, BCG is varies in its effectiveness, it has a waning efficacy, and is responsible 
for false-positive TSTs.  The CFP vaccine also has a waning efficacy and it needs to be 
complexed with adjuvants.  ESAT-6, like CFP, must be complexed with adjuvants.  In 
light of this, Sharma et al. (2001) showed that the drug form and the route of 
administration can alter the effectiveness of the drug.  In 2001, Sharma et al. proposed the 
use of the inhalant drugs Isoniazid (H) and Rifampicin (R) to treat Mycobacterium 
tuberculosis infection.  Findings from their experiment showed that both H and R are 
most effective in microparticle form as opposed to being dissolved in solution (Sharma et 
al., 2001).  Further studies in 2007 showed that the use of H and R in microparticle form 
can promote macrophage activation and NO
production 
will be decreased.  As I see it, this damper on IFN-γ production allows for the existence 
Mycobacterium tuberculosis infection, with IL-17 aiding in its survival. 
. production.  In sync with the production of 
NO. by activated macrophages, the proinflammatory cytokines IL-12 and TNF-α were 
produced the most upon treatment with H and R (Sharma et al., 2007).  As it currently 
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stands, the use of inhalant microparticles is one of the most promising treatments in 
trying to eliminate Mycobacterium tuberculosis infection. 
TNF-α is a proinflammatory cytokine with a big responsibility in defending the 
host against Mycobacterium tuberculosis.  TNF-α is shown to play a key role in 
granuloma formation and macrophage apoptosis.  Mice that failed to produce adequate 
amounts of TNF-α or had a disruption in the gene encoding for the 55kDa TNF receptor 
(TNFRp55-/-
New strides are being made to advance the techniques used to study and develop a 
cure for Mycobacterium tuberculosis.  In recent years there has been more interest placed 
into the role of vitamin D and its influence on Mycobacterium tuberculosis infection.  
) were unable to control infection and eventually died (Flynn et al., 1995).  
More importantly, in humans, Saliu et al. (2006) showed that individuals undergoing 
treatment with TNF-α blockers contract Mycobacterium tuberculosis infection at an 
increased rate.   The three popular commercial TNF-α inhibitor drugs are Humira, 
Remicade, and Enbrel.  Using these drugs, Saliu et al. (2006) showed that Humira and 
Remicade act by inhibiting T cell activation and IFN-γ production whereas Enbrel does 
not.  The findings from their study is important because individuals being treated with 
TNF-α inhibitor drugs for autoimmune diseases such as rheumatoid arthritis have a 
higher risk of contracting Mycobacterium tuberculosis, specifically if they are using 
Humira or Remicade.   At the moment, Enbrel sounds the most promising in the event 
that an individual with an autoimmune disease contracts Mycobacterium tuberculosis 
infection because it still allows for the activation of T cells and the production of IFN-γ, 
two elements absolutely necessary to successfully battle Mycobacterium tuberculosis 
infection. 
85 
 
African-Americans have an increased susceptibility to Mycobacterium tuberculosis 
infection and usually have a more rapid and severe course of disease than Caucasian-
Americans.  Monocytes cultured in serum from African-Americans displayed vitamin D 
levels that were significantly lower than the vitamin D levels from cultures containing 
serum from Caucasian-Americans (Liu et al., 2006).  This occurrence has been attributed 
to the increased skin melanin content of African-Americans that causes decreased serum 
levels of vitamin D (as reviewed by Liu et al., 2006).   
Studies aimed at determining the role that vitamin D has in combating 
Mycobacterium tuberculosis have displayed conflicting results.  Whole blood analyses 
from tuberculosis patients administered a single 2.5mg oral dose of vitamin D displayed 
enhanced immunity (Martineau et al., 2007) and when vitamin D was added to 
Mycobacterium tuberculosis-infected macrophages, the number of viable bacilli was 
reduced (Liu et al., 2006).  Both of these studies support the notion that vitamin D 
promotes macrophage activation and helps to suppress the growth of Mycobacterium 
tuberculosis.  On the other hand, vitamin D has been shown to elicit a suppressive effect 
on the production of TH1 cytokines, specifically IFN-γ and TNF-α.  Prahbu et al. (2009) 
showed that vitamin D suppresses the production of both IFN-γ and TNF-α by CD4+ and 
CD8+ T cells.  Another experiment analyzing the effects of vitamin D on cytokine 
production showed that tuberculosis patients had a significant decrease in the amount of 
IFN-γ and IL-12 produced by their PBMCs (Vidyarani et al., 2007).  These findings 
however, suggest a role for vitamin D in reducing inflammation within the lungs of 
Mycobacterium tuberculosis-infected individuals. 
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The study of cholesterol is another avenue that is being explored to uncover its 
influence on the incidence of Mycobacterium tuberculosis infection.  Cholesterol is a 
structural component of cellular membranes and it accumulates at the site of 
mycobacterial uptake in macrophages (Pieters et al., 2002).  Infected mouse macrophages 
accumulated cholesterol at the site of bacterial entry while cholesterol of uninfected 
macrophages remained distributed within the plasma membrane (Gatfield et al., 2000).  
Mycobacteria bind to cholesterol with high affinity, so in an attempt to uncover the exact 
role of cholesterol in the phagocytosis of tubercle bacilli, cholesterol was depleted from 
the macrophages and the macrophages were observed for the uptake of the tubercle 
bacilli.  The results showed an 85% reduction in the phagocytosis of tubercle bacilli 
(Gatfield et al., 2000).  Gatfield et al. (2000) showed that the presence of cholesterol is 
required for the phagocytosis of tubercle bacilli. With this information future studies 
could focus on identifying the components of mycobacteria that bind to cholesterol.  Such 
findings could lead to strategies that interfere with cholesterol-mediated phagocytosis of 
mycobacteria (Pieters et al., 2002).  Gatfield et al. (2000) also showed that a depletion of 
cholesterol on the cell surface of macrophages could decrease phagocytosis of tubercle 
bacilli however; depleting cholesterol from the surface of macrophages may not serve as 
the best method to prevent Mycobacterium tuberculosis infection given that cholesterol 
has multiple roles in insuring the proper function of cells.  In this case I think more 
research is needed to determine whether the act of reducing or completely depleting 
cholesterol from the surface of macrophages is more detrimental to the function of the 
macrophages in the long run despite the initial benefit that it offers in helping to prevent 
the uptake of tubercle bacilli. 
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Regardless of the direction that future studies decide to take I think that future 
animal studies should focus more on animals harboring latent Mycobacterium 
tuberculosis infection.  By focusing on animals with latent infection, it could possibly 
lead to the design of new treatment options for humans harboring latent Mycobacterium 
tuberculosis infection.  Finding a new way to battle and creating a cure for latent 
Mycobacterium tuberculosis infection will dramatically reduce the incidence of disease 
within the human population.  Animal models should also focus on animals that have 
been previously vaccinated with the BCG vaccine.  Focusing on these animals will allow 
for the study and possible development of a way to prolong the effectiveness and 
longevity of the BCG vaccine.  The problem with current animal models is that most of 
them look at immune reactions in short-term assays and these type of assays do not allow 
time to access the vaccine’s longevity and the degree to which memory cells are or can be 
formed.  Lastly, because Mycobacterium tuberculosis affects the production of the 
cytokines necessary for the successful containing and killing of infection, future drug 
treatments should consider adding cytokines such as TNF-α, IFN-γ or IL-12 to vaccines 
and aerosols as a means to help drive T cell recruitment and activation and NO. 
production.
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Table 4 Summary of Observations 
Summary of Observations 
Mycobacterium tuberculosis  
• Second leading cause of death among all infectious diseases worldwide 
• Approximately 2 million people die each year from this disease 
• One-third of the world’s population remains infected 
 
Apoptosis 
• Cell-cell contact between Mycobacterium tuberculosis-infected and uninfected 
macrophages is required to induce bystander apoptosis 
 
Inducible Nitric Oxide Synthase (iNOS) 
• Mycobacteria-free phagosomes are capable of recruiting iNOS    
 
• Phagosomes containing heat-killed mycobacteria have no effect on iNOS recruitment 
to phagosomes  
 
• iNOS recruitment is disrupted in phagosomes containing live mycobacteria 
 
• Alterations or deletions in one or more of the actin cytoskeleton elements can 
interfere with actin microfilament motility, disrupting the recruitment of iNOS to 
phagosomes 
• iNOS gene-disrupted mice (NOS2-/-
• NOS2
)  have a higher bacterial burden in their lungs 
following Mycobacterium tuberculosis infection    
-/-
• Human Mycobacterium tuberculosis-infected alveolar macrophages are capable of 
producing NO
 mice are capable of mounting an adaptive immune response comparable to 
wild-type control mice upon challenge with Mycobacterium tuberculosis   
.
• Patients with active Mycobacterium tuberculosis infection exhale significantly higher 
levels of NO
  
.
• iNOS expression by alveolar macrophages of tuberculosis patients is significantly 
higher than control subjects 
 than healthy control subjects   
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TLR2 and TLR4 
• Neither TLR2/TLR4 is effective in providing a significant innate immune response 
alone  
 
• Mice deficient in TLR2/TLR4 have a significantly higher bacterial burden than wild-
type mice 
 
γδ T cells 
• Patients with active tuberculosis infection have a significantly reduced number of 
Mycobacterium tuberculosis-reactive γδ T cells in their blood and BAL   
 
• γδ T cells produce IFN-γ in response to Mycobacterium tuberculosis only  
• γδ T cells are capable of producing more IFN-γ on a per cell basis than CD4+
 
 T cells 
in response to tubercle bacilli 
• γδ T cells proliferate faster in a high NK cell-percentage population than in a low NK 
cell-percentage population 
 
IL-17 
• The percentage of IL-17-producing γδ T cells is significantly higher in tuberculosis 
patients than in the healthy donors 
 
• γδ T cells and other non-CD4+ or CD8+
•  γδ T cells produce more IL-17 than CD4
 T cells are capable of producing IL-17 during 
Mycobacterium tuberculosis infection  
+
• IFN-γ-deficient mice produced more IL-17 than wild-type  mice 
 T cells   
 
CD4+ and CD8+
• CD4
 T cells 
+ T cells are two-fold more abundant than CD8+
 
 T cells at sites of 
Mycobacterium tuberculosis infection in both mice and humans 
• There is a significant reduction in the specific lysis mediated by cytotoxic CD8+
 
 T 
cells in the lungs of CD4-deficient mice 
• The cytotoxic activity of Mycobacterium tuberculosis-specific CD8+ T cells is 
compromised in the absence of CD4+
 
 T cells 
• In humans, CD4+ T cells are the primary source of IFN-γ but CD8+
 
 T cells also 
contribute to IFN-γ production  
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BCG Vaccine 
• Variable in its degree of protection against Mycobacterium tuberculosis infection 
 
• Efficacy wanes with time 
 
• Administration of the BCG vaccine during infancy is shown to be highly effective in 
protecting against severe cases of tuberculosis  
 
• BCG vaccination of individuals after the first year of life results in persistent 
tuberculin reactions 
 
• The United States and other industrialized countries with low incidences of 
Mycobacterium tuberculosis infection have discontinued the use of the BCG vaccine 
 
• BCG vaccination affects tuberculin skin tests (TSTs) 
 
Culture filtrate protein (CFP) vaccines 
• Encourages competition for antigen presentation 
 
• Different culture conditions and the  risk of the vaccine possessing both protective 
and deleterious molecules makes it challenging to work with  
 
• Immunization with CFP antigens generate CD4+
 
 T cells that secrete IFN-γ 
• Efficacy wanes with time   
 
• CFP has to be delivered in adjuvant 
Early Secretory Antigenic Target of 6kDa (ESAT-6) 
• ESAT-6 enhances IFN-γ-induced accumulation of iNOS  
 
• ESAT-6 has to be complexed with multiple strong adjuvants to mount a sufficient 
immune response 
Inhalant drugs: Isoniazid (H) and Rifampicin (R) 
• Microparticle form has a better effect on alveolar macrophage activation 
 
• TNF-α and IL-12 are the most significantly induced cytokines following treatment 
with H and R microparticles 
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Important proinflammatory cytokines 
IL-12 
• Humans and mice with mutations in either the IL-12p40 gene or IL-12R gene show a 
reduction in IFN-γ production 
 
• IL-12 links innate and adaptive immunity  
 
IFN-γ 
• Humans and mice with mutations in either the IFN-γ gene or IFN-γR gene are highly 
susceptible to mycobacterial infections 
 
• NO.
 
 production is significantly increased in Mycobacterium tuberculosis-infected 
PBMCs stimulated with IFN-γ 
TNF-α 
• Neutralization of TNF-α impairs the ability of the mice to control Mycobacterium 
tuberculosis infection 
 
• Mice with a disruption in the gene encoding for the 55kDa TNF receptor  
 
(TNFRp55-/-
 
) are unable to control Mycobacterium tuberculosis infection  
TNF-α increases Mycobacterium tuberculosis-induced NO.
 
 production by alveolar macrophages 
• The presence of sTNFR decreases TNF-α-induced apoptosis 
 
• Individuals treated with TNF-α blockers contract Mycobacterium tuberculosis 
infection at an increased rate    
 
• Humira and Remicade inhibited T cell activation and IFN-γ production whereas 
Enbrel does not 
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